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ABSTRACT 
Chloromolaena odorata was screened for its phytochemical properties and 
pharmacological activities. Phytochemical screening of C. odorata indicates the 
presence of terpenoid, flavonoid and alkaloid. GCMS analysis of the leaf extract of C. 
odorata shows four major compounds which are cyclohexane, germacrene, hexadecoic 
acid and caryophyllene. While, HPLC analysis has identify five peaks; quercetin-4 
methyl ether, aromadendrin-4’-methyl ether, taxifolin-7-methyl ether, taxifolin-4’-
methyl ether and quercetin-7-methyl ether, kaempferol-4’-methyl ether and eridicytol-7, 
4’-dimehyl ether, quercetin-7,4’-dimethyl ether. By using the column chromatography, 
three compounds were isolated; 5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one; 
3,5-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-methoxy-chromen-4-one and of 2-
(3,4-dimethoxyphenyl)-3,5-dihydroxy-7-methoxy-chromen-4-one. The toxicity 
evaluation and dermal irritation of the aqueous leaf extract of C. odorata verifies that it 
is non-toxic at the maximum dose of 2000mg/kg. For the formaldehyde induced paw 
oedema evaluation, it proves that the leaf extract of the plant is 80.24% (concentration 
of 100mg/kg) as effective as Indomethacine (standard drug). The methanolic extract 
(100mg/ml) of the plant shows negative anti- coagulant, as it causes blood clot in less 
than two minutes. Meanwhile, the petroleum ether and chloroform leaf extract shows 
negative anti-coagulant, as they prolong the blood coagulation from to two minutes to 
more than three minutes. For the result of anti-microbial evaluation, C. odorata shows 
medium inhibition on S. aureus ATCC 25293, weak inhibition on S. aureus ATCC 
29213 and strong inhibition on P. aeruginosa but no inhibition on the fungi, C. 
albicans. The last evaluation which is wound healing evaluation certifies the rapid 
wound healing to four days (concentration of 300mg/kg) only from six days (using 
acriflavine lotion).  
 
ABSTRAK 
Penyelidikan telah dijalankan mengenai kandungan kimia dan aktiviti 
farmakologikal Chloromolaena odorata L.. Penskrinan fitokimia ekstrak daun             
C. odorata menunjukkan kehadiran terpenoid, flavonoid dan alkaloid. Analisis GCMS  
ekstrak daun C. odorata telah mengasingkan kompaun, germacrene, asid hexadekoik 
dan caryophyllene. Analisis HPLC pula telah menghasilkan lima puncak yang 
dikenalpasti sebagai quercetin-4 methyl ether, aromadendrin-4’-methyl ether; taxifolin-
7-methyl ether; taxifolin-4’-methyl ether dan quercetin-7-methyl ether; kaempferol-4’-
methyl ether dan  eridicytol-7, 4’-dimehyl ether; quercetin-7,4’-dimethyl ether. 
Manakala kromatografi kolum telah mengasingkan tiga kompaun kristal, iaitu,  5,7-
dihydroxy-2-(4-methoxyphenyl)chromen-4-one; 3,5-dihydroxy-2-(3-hydroxy-4-
methoxy-phenyl)-7-methoxy-chromen-4-one dan 2-(3,4-dimethoxyphenyl)-3,5-
dihydroxy-7-methoxy-chromen-4-one. Selain itu, kajian toksiksiti dan keradangan kulit 
menunjukkan bahawa ekstrak daun C. odorata adalah selamat untuk digunakan 
sehingga dos maksimum 2000mg/kg. Di samping itu, kajian pembengkakan aruhan 
formaldehid menunjukkan ekstrak akues daun (kepekatan 100mg/kg) adalah 80.24% 
sama efektif seperti Indomethacine (dadah piawai). Kajian anti-koagulan ekstrak 
methanol pula menunjukkan keputusan negatif kerana ia mempercepatkan kadar 
koagulan kurang daripada dua minit. Manakala ekstrak petroleum eter dan kloroform 
menunjukkan keputusan positif anti-koagulan-ekstrak tersebut meningkatkan masa 
koagulasi darah melebihi tiga minit. Selain itu, kajian antimikrobial menunjukkan kesan 
rencatan sederhana terhadap bakteria S. aureus ATCC 25293, rencatan lemah terhadap 
S. aureus ATCC 29213 dan rencatan kuat terhadap P. aeruginosa. Tetapi tiada kesan 
rencatan terhadap kulat C. albicans. Akhir sekali, ujian luka menunjukkan bahawa 
kadar penyembuhan dipercepatkan (pada kepekatan 300mg/kg) kepada 4 hari 
berbanding 6 hari jika menggunakan Akriflavin (dadah piawai).  
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CHAPTER ONE 
 INTRODUCTION 
 
1.1 General Introduction 
Plants that are used for food flavouring and any medicinal values are known as 
herbs (Hornby and Parnwell, 1965). Herbalism is a traditional medicinal or folk 
medicine practice based on the use of plant or plant extracts. The scope of herbal 
medicine is extended to include fungi and bee products, as well as minerals, shells and 
certain parts of animals (Acharya et al., 2008). Herbs can be divided into four categories 
which are  wild, ornamental, vegetable and spice (Arifin, 2005). 
 
It is undeniable that herbs are the foundation of conventional drugs or modern 
medicine. Aspirin for example was used long ago by the traditional medicine 
practioners as a pain relief medicine (Arifin, 2005). Many plants substances that have 
been synthesized are useful to the health maintenance in human and other animals. The 
derived substances include aromatic compounds (mostly phenols or tannins) and many 
secondary metabolites, of which 12 000 have been isolated and reported (Lai, 2004). In 
many cases, these substances (particularly the alkaloids) serve as plant defence 
mechanisms against predation by microorganisms, insects and herbivores (Lai, 2004). 
Yet many of these herbs and spices are used by humans for food seasoning and they are 
found to yield useful medicinal compounds (Tapsell, 2008). 
 
Herbs and medicinal plants are becoming popular these days as more people are 
using herbal remedies in their daily lives. Herbs are used as treatment for certain 
disease, for maintaining optimum health and also as aphrodisiac. It is believed that 80% 
of the outside industrialised countries rely on herbs for health (Mohd, 2003). 
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However, new scientific findings show that some flavonoids in plants and plant 
products such as herbal medicines and fruit juice are able to induce or inhibit 
cytochrome enzyme in human and animals. Cytochrome enzyme plays an important role 
in metabolising xenobiotics (foreign pollutants, drugs, chemicals and pesticides) that 
enters the human body. Over production or inhibition of the cytochrome enzyme may 
lead to cytoxicity or even death. For example, compounds such as genistein, daidzein 
and coumestrol can combine with the estrogen receptors and cause breast cancer in 
women (Mohd, 2003). 
 
 
1.2 Traditional Medicine in Malaysia 
 In Malaysia, the herbal industry is set to grow 15% annually (Kaur, 2008). The 
market value of the Malaysian herbal supplements and cures industry is expected to 
increase from RM10 billion in 2008 to RM12 billion in 2009. This is due to acceptance 
of herbal medicine by the Malaysian consumers (Kaur, 2009).  
  
 The use of traditional preparation has been increased dramatically in the last two 
years. Medicinal plants such as ‘tongkat Ali’, ‘kacip Fatimah’, Noni fruit and juices 
(from Morinda cirifolia), ginseng, ‘pegaga’, animal products (gamat for example) and 
etc. Some of the natural products are also added to food and beverages such as coffee, 
tea, sweets and even cigarettes (Mohd, 2003). 
 
 Research by University of Malaya (UM) on effects of traditional preparation on 
modern medicine shows that there are many cases of abuse in the medicinal plants and 
consumer trust. The consumption of traditional preparation for a long term may lead to 
detrimental of the human body. This is due to the herbs inhibiting or increasing effects 
14 
 
of modern medicines. Some may even cause the modern medicine to be digested too 
fast before their effects can be seen. Thus, this may lead to toxicity and contraindication 
to the human body (Anonymous, 2003).   
 
 According to the UM research too, certain traditional preparations are added 
with established modern medicines such as dexamethasone (steroid), Betamethasone 
(steroid) glibenclamide and paracetamol. Generally, steroids are added for joint ache 
and arthritis preparation in traditional medicine. Glibenclamide, which is a modern drug 
for diabetic patients, is also found to be added to the traditional preparation for the 
diabetic medicine. Another example is paracetamol which is found in ‘air badak’, which 
is a popular water tonic (Anonymous, 2003). 
 
 However, there is no legal requirement for direct selling companies to conduct 
toxicity screenings on their own products. Therefore, the Ministry of Health and the 
Federation of Malaysian Traditional Medical Practioners are working on the guidelines 
to elevate the status of traditional medicine with scientific and safety measures (Mohd, 
2003).   
 
 
1.3 Family Compositae (Syn. Asteraceae) 
 The compositae or Asteraceae is the largest and most familiar family of 
flowering plants and consists of 1000 genera and 15000 species. Compositae is an 
interesting family because of its characteristic aggregation of reduced flowers into 
specialized inflorescences called capitula (Heywood et al., 1977).  
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 Compositae can be found in a wide range of habitat except in Antarctica. Plants 
of compositae can be found from highly reduced, minute montane annuals (less than     
1cm high, e.g; Cuchanatanea sp.) to relatively large tropical trees up to 20m tall, such 
as Brachylaena sp. The family is the most abundant in subtropical and tropical latitudes 
and is the most evidenced in mountainous areas such as the desert regions. The tribes 
Vernonieae and Eupatorieaehave are largely adapted to mainly tropical or subtropical 
habitats. And the Asteraceae, Inulaea and Lactuceae are adapted to mostly temperate 
and high latitudinal habitats ((Heywood et al., 1977). 
 
 Trees and tree like taxa can be found periodically in remote tribes, in regions 
where phyletic diversification is low, such as mid to low subtropical, slow growing, 
cold enduring, and hard wooden rainforest or in endemics where woodiness is clearly a 
secondary phenomenon (Wagnitz, 1976). Shrubs such as Artemisia occur along rapid 
growing, cold sensitive, herbaceous genera, which are common in warm climate as well 
as perennial, often succulent, saline taxa such as Borrichia sp and Varilla sp (Heywood 
et al., 1977).   
 
Wholly aquatic genera for example, Gymnocoronis sp, Trichoronis sp and 
Shinneria sp and epiphytic taxa are usually found in Eupatoriaea. The extreme 
xerophytic and adaptation is more often found in Asteraea, Inuleae and Heliantheae 
(Heywood et al., 1977). 
 
 According to their habitat types, different dispersal mechanisms can be found 
amongst 5451 species of all tribes of the Compositae. Species which live in the plains 
and prairies tend to have less frequent capillary pappus compared to deciduous forests. 
On the other hand, species of mountainous regions have more frequent capillary pappus 
16 
 
but they have no obvious dispersal adaptation compared to the plants living in the same 
region but at lower allevation. The species of the desert regions have more adhesive 
structures and less wind dispersal pappus. While mesic, riverine and sea coast habitats 
have high percentage of species with no obvious modification of pappus for dispersal.  
From  the annual to perennial shrubs, a concomitant increases in the proportion of 
capillary or plumose pappus (wind dispersal) a decreasing proportion of both adhesive 
or ‘no obvious’ dispersal adaptation (Heywood et al., 1977). 
 
 Table 1.1: The tribes of the Compositae *  
Tribe Name Original spelling 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
 
Vernnonieae    
Eupatorieae     
Asteraceae      
Inuleae            
Heliantheae     
Helenieae        
Anthemideae 
Senecioneae   
Calenduleae 
Arctotideae 
Cynareae        
Mustisieae      
Cichorieae      
Vernoniaceae 
Eupatoriaceae 
Asteroideae  
Inuloideae  
Helianthoideae  
Helianthoideae 
 
Senecionideae  
Calendulaceae 
 
Cynaroideae 
 Mustisaceae  
Cichoriaceae 
 
* Heywood et al., 1977 
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1.3.1 Chemical Constituent of Compositae 
Compositae is very rich in both secondary compounds and also in the numbers 
of complex structures. The common chemical compounds found in compositae are 
terpenoid, sesquiterpene lactones, fatty acid derived from polyacetylenes and the 
polysaccharide fructans (Heywood et al., 1977).  The chemical pattern found in the 
family compositae is shown in Table 1.2. 
 
Common flavonoids in compositae are kaempferol and quercetin (flavonols), 
apigenin and luteolin (flavones). For example, tricin 5-glucoside is the main flavonoid 
found in Cirsium arvense L. Other flavonoids that can be found rarely in the compositae 
family are 6-hydroxylated compound (e.g. quercetagetin (1)  and scutellarein (2), 
methylation of flavonoids (e.g. artemitin, jaceidin, centaureidinm, eupatorin (3), 
eupafolin (4), eupatilin (5) and tetramethoxyflavone), chalcone glycosides (flower 
pigments, dehydro-para-asebotin, sakuranetin, isosakuranetin and 2-hydroxy-4’,5’,6’,4-
tetramethoxychalcone odoratin), flavanonols (e.g. Aromadendrin (6) and its 7-methyl-
ether) and flavonolignans (Heywood et al., 1977). 
  
Phenolic monoterpenoid and large thymol derivatives (both free and esterified) 
are common constituents of certain genera in the compositae family, especially, 
Eupatorium, Inula, Helenium and Gaillardia. Reported volatile constituents found in this 
family are p-menth-3-ene-3, 6-diol (from E.macrocephalum Less), thymol derived 
dehydrobenzofuranoid (species Helenium), Furano sesquiterpenes (from Asteraceae), 
para-quinoid sesquiterpenoids perezone, hydroxyperezone and pipitzols (in Mutisieae) 
and irregular phenolic sesquiterpene (Heliantheae) (Heywood et al., 1977). 
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The seeds of members of the Compositae family are rich in linoleic acid and 
palmitic acid.  Also found in the seeds are lenolenic acid, stearic acid and other minor 
fatty acids. Safflowers (75% linoleic acid and 15% oleic acid) and sunflower seed are 
commercially important for their oil  (Heywood et al., 1977). 
 
Table 1.2: Chemical Pattern of the Compositae * (Heywood et al., 1977) 
Class of compound Location and biological activity 
Presents in all tribes 
1. Inulin-type fructans 
2. characteristics fatty acids 
3. Sesquiterpene lactones 
4. pentacyclic triterpene alcohols 
5. Caffeic acid esters 
6. Methylated flavonoids 
 
In storage organ 
In seed oils 
Mainly in leaves (bitter taste) 
As in esters in fruit pericarp and in lipid 
In leaves ; cynarin 
In leaves and flowers (as yellow pigments) 
Present in most tribes 
7. Acetylenic compounds 
8. Essential oil (including phenolic 
monoterpenes) 
9. Cyclitols’coumarins 
 
 
In roots and leaves  
In leaves and fruits 
 
In leaves and flowers 
 
Present in most tribes 
10. Rubber (polyisoprene) 
11. Pyrrolizidine alkaloids 
12. Triterpene acids 
 
13. Diterpenes 
14. Cyanogenic glycosides 
15. Anthochlor pigments 
16. Chromenes 
17. Fatty and amides 
 
In roots and stems 
In leaves  
Free in flowers; combined with sugar (as saponin) in 
leaves 
In all tissues 
In leaves and fruits  
In yellow flowers 
In leaves and roots  
In roots  
* Heywood et al., 1977 
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O
OH
OH
OH
OH
OH
OH
   
O
O
OH
OH
OH
OH
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        (5) Eupatilin                    (6) Aromadendrin 
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1.3.2 Biological Activities of Compositae  
 Compositae is mostly toxic and rarely taken in human diet or animals’. 
However, it was reported that 25 species of the Compositae family have spasmolytic, 
choleretic, anti-hepatotoxic, anti-helmintic, anti-phloglistic and anti-microbial 
properties.  The compositae family is also rich in terpenoid (essential oil), which can be 
used as food flavouring or liqueurs flavours. Phenolic substances are important too as 
preparation of modern medicines (Heywood et al., 1977).  
 
Table 1.3: Some Important Members of the Compositae Family*  
Species Common name Values 
Achillea ptarmica L. Sneezewort Medicinal plant (sooth 
toothache) 
Anacyclus pyrethrum DC  Insecticidal  
Antennaria dioica L. Gaertner Cat’s foot Medicinal plant 
Arnica Montana L. Arnica Anti-inflammatory 
Artemisia absinthium L. Wormwood Insecticides / liquor flavour 
Artemisia dracunculus L. Tarragon Spice 
Atrium lappa  Produce polysaccharide 
Bellis parennis Daisy Wound healing properties 
Calendula officinalis L. Pot marigold Ornamental plant 
Carthamus tinctorius L. Safflower Produce dye and oil 
Centaurea cyanus L. Cornflower Used as dye 
Chamaemelum nobile L. All. Chamomile Medicinal plant 
Chrysanthemum carinatum 
Schousboe 
Annual 
chrysanthemum 
Ornamental plant 
Chrysanthemum cineraciae  Insecticides 
Cichorium endivia Willd. Endive  Food 
Cichorium intybus L.  Chicory  Coffee substitute 
Cirsum oleraceum (L.) Scop  meadow cabbage  Food 
Cnicus benedictus L. Blessed thistle Medicinal plant 
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Table 1.3 : Continued 
 
Cynora cardunculus L.  Cardoon Food 
Cynora scolymus L. Globe artichoke  Food 
Dahlia variabilis L. Dahlia Ornamental plant 
Dendranthema indica (L.) Autumn 
chrysanthemum 
Ornamental plant 
Echinacea anacyclus  Insecticides 
Echinacea angustifolia DC  Insecticidal  
Echinacea chrysanthemus  Insecticides 
Echinacea heliopsis  Insecticides 
Helianthus annus L. Sunflower  
Produce oil / anticancer 
properties 
Helianthus tuberosus L. Jurusalem artichoke Food/animal feed/ coffee 
substitute/ 
Preparation of fructose 
Ichthyothera terminalis  Fish poison 
Inula helenium L. Elecompane Spice 
Lactuca sativa L. Garden lettuce Food 
Matricaria chamomilla  Antiiflammatory and wound 
healing properties 
Parthenium argentatum Gray  Produce rubber 
Petasites hybridus L. Gaertner Butterbur Anticonvulsive properties 
Pulicaria dysenterica (L.) Bernh Fleabane Insecticidal  
Scarzonera hispanica L. Black salsify Food 
Silybum marianum L. Gaertner Milk thistle Medicinal plant 
Solidago virgaurea L. Golden rod Used as dye 
Tagetes indica L. African marigold Ornamental plant 
Tagetes patula L.  French marigold Ornamental plant 
Tanacetum cinerariifolium 
(Trev.) Schultz Bip 
Pyrethrum Insecticidal 
Tanacetum vulgare L. Tansy Spice / liquor flavour 
Taraxacum bicorne L. Kok  Produce rubber 
Taraxacum officinale pissenlit Diuretic properties 
Tragopogon porrifolius L. salsify food 
Tussilago farfara L. coltsfoot Medicinal plant 
Vernonia sp.  Insecticidal  
*Heywood et al., 1977 
1.4 General Description of Chromolaena odorata L. 
 
 
Figure 1.1: Chromolaena odorata 
 
Chromolaena odorata (L.) King & Robinson or formerly known as Eupatorium 
odoratum L. belongs to the Kingdom Plantae, subkingdom Tracheobionta (vascular 
plants), superdivision Spermatophyta (seeds plant), division Manoliophyta (flowering 
plant), class Magnoliopsida (dicotyledons), subclass Asterdae, order Asterales, family 
Compositae, genus Chromolaena DC (thoroughwort) and species Chromolaena odorata 
(L.). C. odorata is also known as Eupatorium conyzoides Vahl, Eupatorium brachiatum 
Sw. ex Wiestr, Eupatorium atriplicifolium Vahl and Osmia odorata (L.) Schultz-Bip. In 
English, it is known as Siam weed, triffed weed, bitter bush, Jack in the bush, Christmas 
bush, baby tea and so many other names in different countries with different languages 
(King and Robinson, 1970). 
  
C. odorata is native from Florida through the West Indies and Texas through 
central and South America to Argentina (Lieogier, 1997). It has been accidentally or 
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deliberately introduced to the tropical countries, including Guam and Hawaii (King and 
Robinson, 1970). 
C. odorata grows in well drained soil but they still can grow in other different 
type of soil. They grow in a range of vegetation types, e.g. forests (annual rainfall 
1500mm), grassland and arid bushveld (annual rainfall less than 500mm). In arid areas, 
it is restricted to riverbanks. C. odorata grows from close to sea level to over 1000 
meter in elevation.  They are intolerant of frost and are limited by drought, about 90 mm 
of mean annual precipitation (Liogier, 1997).  The seedlings of C. odorata grow well in 
the range of relative humidity from 60 to 70%. There are some experiments which show 
that the seedlings grow well at 30°C and even better on mulched soils at 25°C (King 
and Robinson, 1970).  
 
The C. odorata plants are able to reach to 1 meter or more as free standing shrub 
and 4 meter or more when climbing into other trees or shrubs. Its stems can reach to 
2cm in diameter, while the individual branches are long with relatively few branches. 
The plants are maintained by a system of abundant, yellowish, fine lateral roots. 
Besides, multiple sprouts arise from the crown root and lower stems.  
 
The leaves are opposite, three nerved, are deltoid to ovate-lanciolate and are 
aromatic when crushed. The inflorescences are corymbs of cylindrical heads located on 
the terminal lateral branches. There are about 15 to 25 tubular florets per head, which 
are white, lavender, pink or blue in colour. The seeds have brownish gray to black 
achene that is 4mm long and a pale brown pappus 5 or 6mm long (Liogier, 1997). 
 
C. odorata does not tolerate shade and flourish well in open areas. They can 
form dense stands and suppress the growth of other plants. This is due to the 
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competition and allelopathic effects. The plant will become invasive in the frost-free 
areas from medium to arid woodland which are not water-stressed in the growing 
season. When the plant is dry, it will promote wild land fires (Muniappan, 2000).  
 
In north-eastern India, Siam weed is regarded as a nutrient-demanding early 
succession species. It takes advantage of the flush of soil that becomes available after a 
disturbance (such as fire or land clearing for agriculture) and exhibits relatively high 
foliar natrium, phosphorus and kalium contents (King and Robinson, 1970).  
 
C. odorata blooms annually and is an abundant producer of seeds. Flowering 
and fruiting begins after the plants are one year old (Lieogier, 1997). The flowers are 
pollinated by wind, clinging to hair and clothing of animals and humans. The tiny seeds 
can occur contaminated in imported grass seeds (King and Robinson, 1970). 
  
The individual stems of C. odorata will grow for about two years and die near 
the base of the plant and later will be replaced by new sprouts. The plants’ survival skill 
is very strong-whenever they are being burnt or cut, they can grow back soon. The best 
current control method is mechanical or hand cutting followed by herbicide treatment. 
Partial control can be obtained through the use of aggressive cover crops (Muniappan, 
2000). 
 
 
1.4.1 Overture of C. odorata in Malaysia 
Chromolaena odorata (L.) King & Robinson was first known in Malaysia 
during the war from year 1914 to 1918 (Henderson, 1974). C. odorata is locally known 
as ‘pokok kapal terbang’, ‘pokok Jerman’, ‘pokok Jepun’ and ‘pokok siam’ (Ling et al., 
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2007c).  C. odorata is considered a dangerous weed not only in Malaysia but also all 
over the tropical Asia, Africa, the Western Pacific and northern Australia (McFadyen 
and Skaratt, 1996). It is reported that C. odorata is highly allelopathic and suppresses 
the growth of other plants, especially vegetation and plantation crops, for example oil 
palm, coconut, cashew, rubber, citrus and teak (Azmi, 2000).  
 
In Malaysia, an experiment done by The Rubber Research Institute has found 
that C. odorata suppresses the growth of rubber trees (Anonymous, 1967). In Nigeria, 
the Nigerian Oil Palm Research Institute has requested Commonwealth Institute of 
Biological Control (now known as CABI Bioscience) to conduct a biological control 
programme to overcome the growth of C. odorata. Efforts towards the biological 
research of C. odorata were started in the 1970s. Biological control experiment was 
tested using Apion brunneanigrum Beguin-Billecocq, which is a seed-eating beetle and 
the defoliating larva of a moth. But the experiment was unsuccessful and till now, no 
effective control method has been found yet (Ooi et al., 1998). 
 
 C. odorata is reported to grow along with other weeds for example Melastoma 
malabathricum L. (Melastomatacea), Clidemia hirta (L.) D. Don (Melastomatacea), 
Diodia acimifolia (Wild. Ex Roem & Schutt) Bremek (Rubiaceae), Borreria latifolia 
(Aubl.) Schum. (Rubiaceae), Asytasia gangetica (L.) T.Aderson (Acanthaceae) and 
Dicranopteris linearis Bp (Clecheniaceae). C. odorata is very common on the road side, 
open areas, foreast clearings, abandoned gardens and near the beach (Syed, 1979). 
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1.4.2 C. odorata in the Agricultural Sector 
 The threat of C. odorata to agriculture has been a global concern and studies 
have been done around the world to effectively control the menacing weed. However, 
an evaluation of the progress made has revealed that, through many years of research 
efforts that had been done, the problem of C. odorata has remained unsolved (Ambika 
and Jayachandra, 1980; Ooi et al., 1998).  
 
Despite claims of C. odorata being a menacing weed, there are also some 
research that shows positive contribution of C. odorata to the agricultural sector.  
Research by Bomikole revealed that using C. odorata leaf meal in rabbits’ diet has a 
nutrient profile that is similar to a concentrated feed. Therefore, the leaves of C. odorata 
can be used as an ingredient for formulating animal feed. The C. odorata leaf meal is 
reported to make the production of rabbits more economical and encourage production 
among farmers due to availability of this feed resource (Bamikole et al., 2004).  
 
Another research by Apori et al., also confirmed that the leaves of C. odorata 
have high nutritive values and have the potential to be used as protein supplements to 
ruminants. Their chemical analysis reported that the leaves of C. odorata are high in 
protein content with little or no presence of phenolic antinutritive factors (Apori et al., 
2001). 
 
A different study by Offor and Okonye shows that C. odorata is useful in soil 
fertility restoration by providing essential constituents needed for plant growth and 
protection. It is reported that the leaves of C. odorata have potentials for protecting and 
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maintaining optimum growth for plant in polluted environment (Offor and Okonye, 
2006). 
In Indonesia, a research by Kumalasari et al., reported that the mulch of            
C. odorata improves the growth of corn (Zea mays L.). Their research involved the 
application of C. odorata mulch on planting ground of corn. They concluded that the 
mulch of C. odorata improved the content of the mineral phosphorus and nitrogen in the 
soil.  
 
 
1.4.3 C. odorata in Traditional Medicine 
Leaf extracts of C. odorata added with salt is used as gargle for sore throat and 
colds. The leaves are also used to scent aromatic baths. By adding copious amounts of 
organic matter to soil, it is reported that it may reduced the population of nematodes 
(M’Boob, 1991). The leaves are also used as emergency medication. By pounding the 
leaves till fine and applied to the wound, it can stop the bleeding of wound. 
Furthermore, it can be used during emergency where we can crush the leaves by hand, 
mix with some saliva and applying on the wound (Muhamad and Mustafa, 2004). 
 
In traditional medicine, a decoction of the leaves is used as a cough remedy and 
as an ingredient with lemongrass and guava leaves for the treatment of malaria. In 
Thailand, the juice of the leaf is used as a haemostatic on wounds and anti-
inflammatory. While, decoction of the flowers is used as tonic, antipyretic and heart 
tonic (Bunyapraphatsara and Chokechajiaroenprom, 2000). In Vietnam, fresh leaves or 
decoction of the leaves have been used for the treatment of leech bite, soft tissue 
wounds, burnt wounds, skin infection and dento-alveolitis (Phan et al., 2001b; Ling     et 
al., 2007c). 
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In some studies, it helps to reduce the desire of smoking, cures fever, coughing, 
jaundice and stomach ache. The fresh leaves and extract of C. odorata are used as 
traditional herbal treatment in developing countries for burns, soft tissue wounds and 
skin infections (Phan et al., 2001a). Other medicinal uses include antidiarrhoeal, 
astringent, antispasmodic, antihypertensive, antiinflammatory and diuretic (Iwu, 1993).  
 
 
1.4.4 Chemical Constituents of C. odorata 
 Previous investigation of the leaves and stems of C. odorata has revealed the 
presence of essential oils, steroids triterpenes and flavonoids (Inya et al., 1987; 
Suksamrarn et al., 2004; Talapatra et al., 1974, Bose et al., 1994). Flowers of this plant 
species have been subjected to investigation for essential oils, fats alkaloids and 
favonoids (Baruah and Leclerq, 1993). The reported isolated compounds of this plant 
are shown in Table 1.4.  
 
Table 1.4: Chemical Constituents in Extracts of C. odorata 
Part of plant Chemical constituent References  
Flower (aqueous 
extract) 
 3,5,4’-trihydroxy-7-methoxyflavanone  
 5,7,3” ” ’-trihydroxy-5’-methoxyflavanone   
 3,5,7-trihydroxy-4’-methoxyflavanone 
Odunbaku and 
Ilusanya, 2008    
Flower 
 Akuranetin  
 Persicogenin   
  5,6,7,4’-tetramethoxyflavanone  
 4’-hydroxy-5,6,7-trimethoxyflavanone  
  2’-hydroxy-4,4’,5’,6’-tetramethoxychalcone  
  4,2’-dihydroxy-4’,5’,6’-trimethoxyflavanone  
  Acacetin   
  Luteolin 
Suksamrarn et 
al., 2004; 
Pisutthanan et 
al., 2006 
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 5, 7-dihydroxy-6-4’-dimethoxyflavanone (Latest) 
   
Table 1.4: Continued 
 
Whole plant-
above ground 
parts 
(dichloromethane 
extract) 
 2’-hydroxy-3,4,4’,5’,6’-pentamethoxy-chalcone  
 2’,4-dihydroxy-4’,5’,6’-trimethoxychalcone  
 Scutellarein tetramethyl ether 
 Sinensetin   
 2’-hydroxy-4,4’,5’,6’-tetramethoxychalcone 
Barua et al., 
1978 
 
Whole plant 
(ethanol  and 
methanol extract) 
 Aromadendrin 4’ methyl ether  
 Eriodicytol 7,4’-dimethyl ether   
 Naringenin 4’-methyl ether   
 Taxifolin 4’-methyl ether ; taxifolin 7-methyl ether  
 Quercetin 7,4’-dimethyl ether  
 Kaempferol 4’-dimethyl ether  
 Quercetin 3-O-rutinoside  
 Quercetin 4’-methyl ether  
 Quercetin 7-methyl ether 
Ling et al., 
2007a; 
Suksamrarn et 
al,2004 ;  
 Ling et al., 
2007b 
 
 
Leave (ethanol 
extract) 
 Tamarixetin  
 Trihydroxymonomethoxyflavanone  
 Pentaethoxyflavanone  
 Dihydroxytrimethoxychalcone  
 Eupatillin ; 5,6,7,4’-Tetramethoxyflavanone  
  5-Hdroxy6,7,3’,4’-tetramethoxyflavone  
 Kaempferide  
 Protocatechuic acid  
 p-Coumaric acid 
  p-Hydroxybenzoic acid  
 Ferulic acid  
 Vanillic acid  
 Sinensetin  
 Rhamsetin  
 Tetrahydroxymonomethoxyflavanone 
Phan et al., 
2001b 
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Table 1.4: Continued 
 
Root and flower 
head (methanol 
extraction) 
 7-angeloylretronecine  
  9-angeloylretronecine  
  Supinine  
 Intermidine 
 Lycopsamine  
 Rinderine 
 Echinatine  
  3’-Acetylrinderine 
Biller et al., 1994
Whole plant 
(aqueous extract) 
Essential oils ; 
 Alpha-pinene  
 Limonene  
 p-Cymene  
 cadinene   
  Beta-caryophyllene   
 Camphor 
  Cardinal  
 Germacrene D 
Dieneba et al., 
1992 
Whole plant 
(cold light petrol 
b.p. 60-80°) 
 Lupeol  
 β-amyrin  
 Salvigenin 
Talapatra et al., 
1974 
 
 
 
 
 
 
 
 
 
 Figure 1.2: Chemical Structures of Flavonoids Isolated from the Leaves Extract of 
C.  odorata *  
OR4
O
OOH
R3
R1
R2O
 
 
(7)  Aromadendrin 4’ methyl ether R1=OH; R2, R3=H;R4=CH3 
(8)  Eriodicytol 7,4’-dimethyl ether R1=H; R2, R4= CH3;R3=OH 
(9)  Naringenin 4’-methyl ether R1,R2, R3=H; CH3;R4=CH3 
(10) Taxifolin 4’-methyl ether R1,R3=OH;R2=H; R4=CH3 
(11) Taxifolin 7-methyl ether R1,R3=OH;R2= CH3; R4= H 
 
 
 
 
OR4
O
OOH
R3
OR1
R2O
 
 
(12) Quercetin 7,4’-dimethyl ether R1, R3=H;R2, R4=CH3 
(13) Kaempferol 4’-dimethyl ether R1, R2,R3= H; R4=CH3 
(14) Quercetin 3-O-rutinoside R1=glu(6-1)rham;R2, R4=H; R=OH 
(15) Kaempferol 3-O-rutinoside R1=glu(6-1)rham;R2, R3, R4=H 
(16) Quercetin 4’-methyl ether R1, R2=H;R3=OH;R4= CH3 
(17) Quercetin 7-methyl ether R1,R4=H;R2= CH3 ;R3=OH 
 
 
 
 
 
* Ling et al, 2007b  
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1.4.5 Biological Activities of C. odorata 
 Several classes of flavonoids have been isolated from C. odorata extracts which 
are three flavanones and one flavone that proves to be responsible for blood 
coagulation. The extract of C. odorata is also reported to have strong anti oxidant effect 
(Phan et al., 2001b). It has also been reported to have anti-inflammatory, astringent, 
diuretic and hepatotropic activities (Watt and Breyer-Brandwijik, 1962). Some of the 
reported biological activities of C. odorata are shown in Table 1.5. 
 
 
Table 1.5: Some Biological Activities of C. odorata 
Part of plant  Biological Activity Reference  
Aerial part  
 Aqueous extract  
and essential oil  
 Anti-malarial against  
 Anti-inflammatory 
 Antibacterial against 
Pisutthanan et al., 2006 
Whole plant extract of; 
 Ethanol, 
dichloromethane and 
methanol  
 
 Analgesic 
 Anti-inflammatory 
 Antipyretic  
 Antibacterial against  
Irobi, 1997 ; Odunbaku 
and Ilusanya, 2008; 
Oweyele et al., 2008 
 
Leaf  extract of; 
 Methanol, ethanol and 
aqueous 
 Antioxidant 
 Anti-inflammatory 
 Wound healing properties 
 Anti-staphylococcal  
Ling, 2006 ; Phan et al., 
2001a ; Phan et al., 2001b ; 
Akinmoladun et al., 2007 ; 
Dieneba et al., 1992 
Flower 
 Antibacterial against 
Mycobacterium tuberculosis 
 Anticancer  
Suksamrarn et al., 2004 
 
Methanol extract of whole 
plant 
 Platelet activating factor 
(PAF) receptor binding 
inhibitory activity 
Ling et al., 2007b 
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1.5 Objectives of Present Study 
 
The main objectives of this study are: 
1. To screen the chemical constituents of Chromolaena odorata (L.) 
2. To screen the bioactivity of Chromolaena odorata (L.) 
3. To screen the wound healing activity of Chromolaena odorata (L.) 
4. To isolate some flavonoid compound of Chromolaena odorata (L.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Chapter Two 
 
   MATERIALS AND 
METHODS 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Plant Materials  
In this study, the leaves of the plant Chloromoena odorata were investigated for 
its biological activities and chemical constituents. C. odorata was collected in 
University of Malaya, Kuala Lumpur and was authenticated by Prof. Dr. Muhamad bin 
Zakaria and Prof. Dr. Ong Hean Chooi. The leaves were carefully selected to avoid 
contamination by Mikania sp, which is seen to grow along side C. odorata. Then, the 
leaves were air dried for 14 days and after that ground into powder for experimental use. 
 
 
2.2 Extraction of Plant Material 
200g of the dried powdered leaves were extracted successively with different 
solvents of hexane, petroleum ether (b.p. 40-60C), chloroform and methanol. Then, 
each extracts were filtered and concentrated to dryness using a rotary evaporator at 
50°C. The crude extracts were subsequently kept in the refrigerator for further studies.  
 
 For gas chromatography mass spectrum (GCMS) analysis, 250g of fresh leaves 
were collected and immediately immersed in 250 ml of HPLC grade solvents of hexane, 
chloroform and petroleum ether for 12 days. Then, they were filtered and evaporated 
using a rotary evaporator.  
 
 For the anti-inflammatory and toxicity evaluations, the powdered leaves were 
extracted using distilled water. The concentration of the leaf extracts were prepared 
according to the weight of the test subjects. 
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2.3 Instrumentation 
 Melting points were recorded on Optical Polarising Microscope with camera 
(Olympus BX51) equipped with Mettler Toledo FP82HT hot stage and the 
magnification is 20 times. The infrared spectra were taken in KBR. 1HNMR, analyzed 
at 400MHz and 13CNMR were analyzed at 100MHz. Both spectras were determined in 
deuterated methanol and chemical shifts are in δ units. The HPLC analysis was 
conducted using Shimadzu gradient HPLC. While GCMS analysis was performed on 
Hewlett–Packard Model 6890 combined with gas chromatography of Hewlett-Packard 
Model 6890. The isolation of compound was done by column chromatography. 
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2.4 Preliminary Evaluation (Biohealth Science Lab. Manual, 2003) 
2.4.1  Preliminary Powder Extract Screening 
One drop of 1mg/ml aqueous extract of C. odorata was added into test tubes with the 
following reagents:  
 Dragendorf 
 Meyers 
 Anisaldehyde 
 Potassium hydroxide 
 Vanillin 
 Ninhydrin 
Changes of colour was observed and recorded according to Table 2.1. 
 
 
 Table 2.1: Standard Observation of Extract in Reagent 
 
Reagents 
Component 
Dragendorft Meyer’s Anisaldehyde 
Potassium 
hydroxide 
Vanillin Ninhydrin 
Day 
light 
Alkaloid Orange White      
Terpenoid   Purple, blue, 
red 
 Purple, blue, 
grey 
  
Phenol     Purple/pink   
Flavonoid   Red/coloured     
Essential oil   Coloured     
Saponin   Black/blue     
Quinon    Purple/red    
Amino acid      Purple/Red  
Steroid   Green/gray     
Chlorophyll       Green 
Carotene       Orange
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2.4.2 Colour Test  
Each 5 mg of blended sample was tested with 10 drops each of the following solvents: 
 Concentrated ammonium sulphuric acid (H2SO4) 
 Concentrated hydrochloric acid (HCl) 
 5 % natrium hydroxide (NaOH) 
 5% kalium hydroxide (KOH) 
 25% ammonia hydroxide (NH4OH) 
 5% ferum chloric (FeCl3) 
Changes of colour was observed and recorded, according to Table 2.2. 
 
Table 2.2: Standard Observation for Colour Test 
Solvent Colour Compound detected 
Sulphuric acid Black  Terpenoid 
Hydrochloric acid Green 
 Flavonoid  
 Anthocyanin 
Potassium hydroxide 
 Purple 
 Red 
 Parahydroxyqinon 
 Antraquinon  
Ferric chloride Blue or green  Phenolic substances 
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2.5 Chromatographic Techniques  
2.5.1 Thin Layer Chromatography (TLC) 
2.5.1.1 TLC for Phytochemical Screening of Leaf Extracts 
Commercial aluminum sheets Silica gel 60F245 of layer thickness 0.2 mm 
(Merck, Art. 5554) was used as TLC plates. The TLC strips were developed in several 
solvent systems to screen the secondary metabolites of the leaves. The extracts were 
diluted in different solvents and spotted onto the strips using fine glass capillaries to 
make fine spots.  
 
The leaves extract was spotted 1.5 cm from the bottom of the strip and 
developed to 1 cm from the top of the TLC strip. The strips were developed in saturated 
chromatographic tank at room temperature. The spots were visualized by examination 
of strips under UV light, followed by staining with iodine or using other 
chromatographic reagents. The strips were sprayed with reagent, vanillin sulphuric and 
Anisaldehyde-sulphuric reagent.  
 
2.5.1.2 Visualizing Reagents 
(a) Reagent Vanilin-Sulpuric acid-for detection of terpenoids 
1.5% by volume of concentrated sulphuric acid was added to a mixture of 1% vanillin 
in absolute ethanol. The TLC plates were heated after spraying of this reagent to 
develop colours. 
 
(c) Reagent Anisaldehyde-Sulfuric acid-to detect flavonoid and  
      volatile oil 
Reagent is prepared by mixing 0.5ml of anisaldehyde with 10ml of glacial acetic acid 
followed by the addition of 85ml methanol and 5ml of concentrated sulphuric acid. 
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(d) Reagent Potassium Hydroxide-to detect quinon and quomarin 
This reagent is also known as 5% ethanolic KOH. It is prepared by mixing 5g KOH 
with 100ml ethanol.  
 
 
2.6 Column Chromatography 
 The leaves extracts were fractioned by column chromatography on silica gel 60 
(Merck, Art. 7734, 70-230). The gel was made into slurry by different solvents 
depending on the solvents used to extract the leaves.  
 
 
Table 2.3: Solvent System 
Plant Extract Solvent  system 
Hexane 
 chloroform : hexane (80:20)   
 100% chloroform 
Methanol  
 toluene : ethylacetate (70 : 30)  
 chloroform : petroleum ether (90 : 10) 
 
 
The column used was glass column sizes 3 x 70cm and 2 x 60cm. Then, each 
packed column was left to equilibrate for 12 hours before used. The flow rate of the 
solvent systems was regulated manually by means of a stopcock at the rate of 
approximately 5ml/min. The eluates were collected and grouped into a series of 
fractions after screening by TLC. 
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2.7 High Performance Liquid Chromatography (HPLC) Analysis 
1g of dried powdered sample was extracted overnight in 10ml HPLC grade 
methanol (Fisher Scientific). Water used was also HPLC grade and acidified to pH 3.0 
with phosphoric acid. Qualitative analysis was made in step gradient mode, with the 
proportion of methanol and water 1:1 (analysed from 0 to 10 minutes) and 7:3 (analysed 
from 10 to 20 minutes) at a flow rate of 1mL/min. The injection volume was 10µL and 
the eluate was monitored at 250, 350 and 339nm. The filtered methanol extract was 
injected in Thermo ODS Hypersil C18 column (250 x 4.6 mm, 5μm).  
 
 
2.8 GCMS Analysis 
Fresh leaves of C. odorata was collected, cleaned and immersed into HPLC 
grade solvents of hexane, chloroform and petroleum ether. This is to ensure that the 
essential oil is not oxidized. The leaves were extracted in the solvents for 12 days. Then, 
they are filtered three times using Whatman (No. 1) filtering paper. Before injecting the 
sample into the GCMS, the samples were evaporated to approximately 5ml for each 
solvent. The sample was injected into the GCMS column using vial containing 
chloroform. One drop of each sample is mixed with approximately 3ml of HPLC grade 
chloroform. The GCMS machine used was Shimadzu QP-5000 combined with 
Shimadzu GC-17A. 
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2.9  Biological Activities Evaluations  
2.9.1  Toxicity Evaluation 
2.9.1.1 Acute Oral Toxicity Evaluation (Chan et al., 1982; Delporte et al., 2003) 
 Acute oral toxicity test was done according to Chan et al., 1982 and Delporte et 
al., 2003, with few modifications. The animals used were white albino mice, bought 
from the Institute of Medical Research (IMR). 0.05 ml of water extract of C. odorata 
was orally dosed using a feeding syringe to 25g fasted mice. The mice were given the 
maximum dosage of 2000 mg/kg of the leaves extract and 0.9% of saline was used as 
control.  
 
2.9.1.2 Dermal Irritation Evaluation (Martin, 1982; Ilham et al., 1995) 
            Dermal irritation evaluation was done according to Martin, 1982 and  
 Ilham et al., 1995 with few modifications and the OECD Guidelines for testing of 
chemicals (Guidelines number 404: Acute Dermal Irritation/Corrosion, Paris Cedex, 
May 12, 1981). The animals used were white albino mice, bought from Institute of 
Medical Research (IMR). 0.5 ml of water extract of C. odorata was used directly on 
6cm2 of the shaven dorsal abdominal skin. The hair was carefully shaven to ensure that 
there was no abrasion and injury on the skin. Saline (0.9%) was also included as control 
negative. 
 
 The animals were separated in to two groups (n=3 for each group) and were 
stabilized for 24 hours after shaving prior to application of the substance. Then, any 
signs of colour changes or blister appearance on the skin were checked. Also, mortality 
and any abnormal responses were observed, such as, spontaneous activity, writhing, 
convulsion, gasping, hind limb placing, positional and traction. Irritation measured 
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according to Draize scale. Mortality and visible abnormal responses were observed 
through out the 14 days of evaluation. 
 Table 2.4: Characterization of erythema, eschar and oedema 
Condition Characteristic 
Erythema Erythema is an abnormal redness of the skin due to dilation of 
redness of superficial capillaries of the skin causing inflammation. 
Oedema  Abnormal accumulation of fluid beneath the skin is known as 
oedema. This leads to puffy appearance often to a limb, most 
commonly the leg. 
Eschar Sloughed off dead tissues, caused by burn or cauterization.  
 
 
 
 
2.9.2 Antimicrobial Activity Evaluation 
2.9.2.1 Test organisms 
 The antimicrobial screenings consist of four bacterias and one fungi as test 
organisms. All species of the bacteria were obtained as clinical isolates from the 
Department of Medical Microbiology, Faculty of Medicine, University of Malaya 
except for Klebsella pneumonia, which was obtained as laboratory isolates from the 
Department of Genetics and Cellular Biology, Faculty of Science, University of 
Malaya. The yeast sample was also obtained as clinical isolates from the Department of 
Medical Microbiology, Faculty of Medicine, University of Malaya. All the organisms 
represent the different existing groups of human pathogenic bacteria and fungi as listed 
in Table 2.5.  
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Table 2.5: Test Organisms for Antimicrobial Activity Evaluation 
 
Group Species  
Gram positive bacteria 
Staphylococcus aureus ATCC 252593 
Staphylococcus aureus ATCC 29213 
Gram negative bacteria 
Escherichia coli ATCC25922 
Escherichia coli ATCC35213 
Klabsiella pneumonia 
Pseudomonas aeruginosa 
Yeasts Candida albicans 
 
 
2.9.2.2 Media for Microbial Cultivation and Maintainace 
 Four types of culture media were used (Table 2.6). Each medium was prepared 
to manufacturers’ specification and adjusted to its appropriate pH before sterilized by 
autoclaving at 121ºC for 15 minutes. Then, about 20 ml of sterile agar media was 
poured into sterile petri dishes. The broth or liquid media were distributed to final 
containers before autoclaving. 
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Table 2.6: Culture Media for Microbial Growth 
Medium Purpose Preparation 
Mueller Hinton Agar 
(OXOID) 
Semi-quantitative 
antibacterial test 
38 g was suspended in 1 
liter of distilled water and 
brought to boil to dissolve 
completely. pH = 7.4 ±2 
Mueller Hinton Broth 
(OXOID) 
Bacterial cultivation and 
quantitative antibacterial 
test 
21g was dissolve to 1 liter 
of distilled water and 
distributed to final 
containers. pH 7.4 ±2 
Brain Heart Agar 
Fungal cultivation and 
maintaince. 
Semi quantitative antifungal 
test. 
52g was suspended in 1 litre of 
distilled water and brought to 
boil to dissolve completely. pH: 
7.4 ± 0.2 
Brain Heart Broth 
Fungal cultivation and 
quantitative fungal test. 
37g was dissolve to 1 liter 
of distilled water and 
distributed to final 
containers. pH 7.4 ±2 
 
 
2.9.2.3 Inoculums for Antimicrobial Evaluation 
 Cultures of bacteria were prepared one hour before antibacterial test were being 
done. One colony of each bacteria tested was mix in 5ml sterilized Mueller Hinton 
Broth. The density of each inoculum was standardized using the 0.5 McFarland 
standards. The concentrations of the resultant suspensions of bacteria are approximately 
108 cells/ml.  
 
Conidial suspensions of the test fungi were also prepared one hour before the 
antifungal test. The tested fungi was also standardized using McFarland but then diluted 
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to 107cells/ml by adding 225ml of sterile Brain Heart broth to 25 ml of suspensions of 
the test fungi.  
2.9.2.4 Paper Disc Diffusion Assay (Bauer et al., 1966; Brown and Blowers, 1978) 
 The bacterial suspension (refer table 2.5)  were evenly spread on the surface of 4 
mm thickness of Mueller Hinton Agar (MHA) plates and the fungi suspensions on 
Brain Heart Agar (BHA). Sterile cotton swabs were used to produce uniform growth 
organisms and Kirby-Bauer swabbing technique was used. 
 
 Petroleum ether, chloroform and methanol extracts of the leaves of   C. odorata 
was used as test extracts. Concentrations used for each solvent were 100, 200, 300, 400, 
500, 600, 700 and 800mg/ml. Each extract was then loaded on a 6mm diameter disc 
(Whatman No.1 filter paper). Each disc was loaded with 10µl of extract and then 
evaporated. After evaporation of the solvents, the discs were placed in good contact on 
the seeded agar plates. 
 
 Chloramphanicol and 5-fluorocystina with the concentration of 1 mg/ml was 
used as reference antibiotic for bacteria and fungi respectively. Empty disc and disc 
with solvents were also used as negative references. 
 
 Incubation was done at 37˚C for 24 hours. Each extract and control was 
employed in triplicate for each organism. The diameter of clear zones produced around 
the discs (if present) was measured after the incubation time. 
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2.9.3 Anti-Inflammatory Studies (Suleyman et al., 1999); Suleyman and Emin, 
2001; Suleyman et al., 2002) 
2.9.3.1 Formaldehyde-Induced Paw Edema in Rats 
White albino mouse (120±2g) was bought from Institute of Medical research 
(IMR). Female and male mouse were separated in different cages and acclimatized to 
the new environment for one week. Before anti-inflammatory evaluation, the animals 
were fasted for 12 hours. Aqueous extract of C. odorata was used in doses of 50, 100, 
300, 500 and 1000mg/kg. Tween 80 was used as vehicle to dilute the plant extracts. 
Saline water with Tween 80 and 10mg/kg of Indomethacine were included as control 
negative and positive respectively. The animal was separated into seven groups, 
according to different extract concentrations, saline solution and Indomethacine drug. 
Each group consisted of three animals.  
 
Next, each mouse was administered orally with the extracts using a feeding 
syringe. Before the injection of formaldehyde, the hind paw of each mouse was 
measured. One hour after the final drug administration, formaldehyde, 0.2ml (1% w/v) 
was subcutaneously injected into the plantar surface of the right hand paw. The volumes 
of the hind paws were measured after injection at third, sixth and 24th hour, till the 
inflammation disappeared (original paw volume obtained). The edema was expressed as 
a percentage of pre-injection right paw volume. Finally the anti-inflammatory effects of 
animals that received C. odorata extracts were compared with those in the control group 
and indomethacine administered group.  
 
50 
 
The ratio of anti-inflammatory activity  was calculated by the following 
equation : anti-inflammatory activity (%)=(1-D/C) x 100, Where D represents the 
percentage of difference of the paw volume after the administration of extract and C 
represents the percentage difference of the paw volume in the control group 
 
 
2.9.4 Blood Coagulation Evaluation (Mary et al., 2003) 
Fresh blood from rats was used for this evaluation. First, 10 drops of fresh blood 
was dropped onto a white plate. Then, leaves extracts of C. odorata was added on the 
blood. PE, CHCL3 and MEOH extract was used at the concentration of 100, 300 and 
500mg/ml each. Saline, PE, CHCL3 and MEOH solvents were used as control. The time 
for the blood drop to coagulate was recorded and compared between solvents, saline 
water and leaf extracts. This evaluation was done in triplicate. 
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2.10 Dermal Wound Healing Evaluation (Villegas et al., 1997; Rashed et al., 2003; 
Gomez-Beloz et al., 2003) 
White albino mice (weighed 25g) from University Malaya animals’ house were 
used. Before the wound incision was made, the hair on the dorsal back of each animal 
was removed by shaving and ethanol (70%) was used as an antiseptic. Then, the 
animals were fainted using diethyl ether. An incision wound was made on the dorsal 
side of each mouse vertically by using a shaving razor with the length of 10mm on the 
skin from a predetermined shaved region. The wound was left undressed to the open 
environment and no local or systemic anti-microbial agents were used. The mice were 
distributed in groups randomly and each mouse was placed in separate cage.   
 
After that, aqueous leaf extract of C. odorata was applied on the wound of each 
animal using a cotton bud. The concentration used was 100, 300 and 500mg/ml. Saline 
water (0.9%) and Acriflavine lotion was also included as negative and positive control 
respectively. Observation was done for 16 days, till the last animal healed from the 
wound. Inflammation, scabbing, scarring and animal behaviour were checked and 
recorded throughout the evaluation. 
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CHAPTER 3 
RESULTS AND DATA ANALYSIS 
 
3.1 Phytochemical Studies 
3.1.1 Preliminary Evaluation 
 The preliminary evaluation was done using aqueous leaves extract of                 
C. odorata. Each drop of the extract was added into test tubes containing 1ml of the 
dragendorf, Meyer’s, potassium, anisaldehyde, vanillin and ninhydrin reagents 
respectively. The observation of this evaluation is based on the changes of colour of 
each reagent. The colour changes was then compared to standard observation of the 
reagent (please refer to Table 2.1, page 26).the observation for the aqueous leaves 
extract of C. odorata is shown in Table 3.1. 
 
Table 3.1: Observation of Preliminary Evaluation 
 Reagent Observation Remark 
1.  Dragendorff Orange with precipitate Presence of alkaloid 
2.  Meyer’s White with precipitate  Presence of alkaloid 
3.  Potassium No changes No presence of quinone 
4.  Anisaldehyde dark green Presence of essential oil 
5.  Vanillin Brown Presence of flavonoid 
6.  Ninhydrin  No changes  No presence of amino acid 
 
 
From Table 3.1, it is known that there was presence of flavonoid, alkaloid and 
essential oil in the crude extract of C. odorata. But presences of amino acid or quinone 
were not detected in the crude extract. 
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3.1.1.2 Colour Evaluation 
 The colour evaluation was done by adding 10 drops of each of the prepared 
solvent (as listed in Table 3.2) to 5mg of the blended leaves sample of C. odorata. 
Again, changes of colour of the blended sample of the leaves of C. odorata was 
observed and recorded. The changes of colour was compared to standard observation of 
each of the solvents, according to Table 2.2 (please refer page 27). The observation of 
the colour evaluation is as shown in Table 3.2. 
 
Table 3.2: Results of Colour Evaluation 
Solvent Observation of colour Remark 
H2SO4 
Green to dark brown Positive presence of  terpenoid,  
phenilpropane etc 
HCl Green to  yellowish green 
Positive presence of antocyanin and 
flavonoid 
KOH Green to bright greenish yellow Negative presence of presence quinone 
FeCl3 Dark green 
Positive presence of phenolic substances 
and tannin 
 
  
 According Table 3.2, it is known that there are presences of terpenoid, flavonoid 
and phenolic substances in the blended leaves sample of C. odorata. It is also known 
that there is no presence of quinone.  
 
 
 
 
 
 
 
55 
 
3.1.2 Compound Identification of the Crude Extract 
3.1.2.1 Gas chromatography Mass Spectrum (GCMS) Analysis  
The crude Petroleum ether, hexane and chloroform extracts of C. odorata were 
subjected to GCMS analysis. GCMS analysis was performed on Hewlett–Packard 
Model 6890 combined with gas chromatography of Hewlett-Packard Model 6890. The 
isolation of compound was done by column chromatography. The solvent extraction of 
the fresh leaves was done in 12 days. The extracts were then filtered thrice to ensure 
that there was no presence of impurities. After that, the extracts were evaporated to 
10ml and only compounds with SI (Standard Index) higher than 80% were recorded, so 
that accuracy was ensured. 
 
 The GCMS analysis of the essential oil from the hexane extraction had detected 
three compounds which are caryophyllene (20), germacrene D (21) and hexadecoic acid 
(24). Meanwhile, the petroleum ether extraction detected three compounds which are 
germacrene D (21) and hexadecanoic acid (24). Lastly, the chloroform extract detected 
only one compound and that was germacrene D (21). It was noticed that the compound 
Germacrene D (21) was found in all three solvent extractions. The compounds detected 
by the GCMS analysis are shown in Table 3.3. 
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Table 3.3: Detected Compounds of GCMS Analysis 
 
Extraction 
solvent  
Peak 
No. 
SI 
(%) 
Compound (Name and 
Synonym) 
Mol. form 
Mol. 
Weight 
(g/mol) 
Hexane 7 89 
 Germacrene D 
 1, 6-cyclodecadine, 1-
methyl05methylene-
8methylethyl 
 
C15H24 204 
 14 94 
 Hexadecanoic acid 
 Pentadecanecarbocyclix 
acid 
 Palmitic acid 
 
C16H32O2 256 
 18 90 
 
 Caryophyllene 
 
C15H24 206 
Petroleum 
ether 8 91 
 Hexadecanoic acid 
 Pentadecanecarbocyclix 
acid 
 Palmitic acid 
 
C16H32O2 256 
 11 87 
 Germacrene D 
 1, 6-cyclodecadine, 1-
methyl05methylene-
8methylethyl Germacrene 
D 
 
C15H24 204 
Chloroform 5 88 
 Germacrene D 
 1, 6-cyclodecadine, 1-
methyl05methylene-
8methylethyl 
 
C15H24 204 
 
 
 
 
3.1.2.2 HPLC Analysis  
The HPLC system consisted of a pump and a diode array detector. The system 
was controlled by Shimadzu LC Solution. The column used was thermo ODS hypersil 
C18, sized 250 x 4.6 mm with 5µm particle size. Solvents used were HPLC grade 
bought from Fisher Scienctific. Water was also HPLC grade and acidified to pH 3.0 
with phosphoric acid. The crude extract of C. odorata was extracted from methanol. 
 
 The qualitative analysis was made in step gradient mode, with the ratio of 
methanol: water, 1:1 (0 to 10 minutes) and 7:3 (10 to 35 minutes) at a flow rate of 
1mL/min. The injection volume was 10 µl and the eluate was monitored at 250nm, 
350nm ad 339 nm. Identification of the compound detected was done by comparison 
with Ling et al., 2007a. The HPLC analysis was able to detect five peaks and is shown 
in Table 3.4.  
 
Table 3.4: Compound Detected by HPLC Analysis 
Peak no. 
Retention time 
(Minute) 
Compound detected 
17 15.71  Quercetin-4 methyl ether    
18 16.23 Aromadendrin-4’-methyl ether  
20 17.20 
Taxifolin-7-methyl ether; taxifolin-4’-
methyl ether and quercetin-7-methyl ether 
22 19.92 
Kaempferol-4’-methyl ether and   
eridicytol-7, 4’-dimehyl ether 
23 21.19 Quercetin-7,4’-dimethyl ether 
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3.1.3 Column Chromatography 
 The methanol crude extracts of C. odorata were subjected to column 
chromatography. The column sizes used were 2 x 60cm, 3x 70cm and 5 x 90cm. For 
each sample, the concentration used was 3mg of extract for 50 g of silica gel (Merck, 
F124). Meanwhile, the fractions were collected 5ml for each eluant vial. Then, fractions 
collected were grouped in series of fractions after monitoring with TLC and the 
Anisaldehyde-sulphuric spray reagent. Each series were then treated separately to 
isolate and purify the compounds present by TLC. 
 
 The petroleum extract (column size, 2x 60 cm) yield 39 vials of eluant with 18 
vials that showed single compound, tested through TLC and the anisaldehyde spray 
reagent. The colour observed was purple (6 vials), red (8 vials), yellow (2 vials), orange 
(1 vial) and blue (1 vial). Initially, this showed that there are presence of essential oil, 
flavonoid and terpenoid.  
 
For the column size of 3 x70cm (also the petroleum extract), 85 vials were yield 
and 20 vials showed single compound through TLC. The anisaldehyde spray reagent 
showed 5 vials of purple coloured compound and 32 vials of red coloured compound. 
Preliminary, these showed that there are presences of terpenoid and flavanoid 
compounds. But no pure crystal was obtained from all the eluant collected. 
 
 The chloroform extracts on the other hand, showed presence of flavanoid, 
terpenoid and essential oil. But no pure compound crystal was yield.  The 2 x 60cm 
column yields 39 vials of eluant. All eluant were tested with TLC and sprayed with 
anisaldehyde spraying reagent. Also for the chloroform extract, no eluant re-crystallised 
after evaporation.  
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As for the of methanol extract of C. odorata with the column size of 3 x 70cm, 
150 vials of 1ml were collected. And 13 vials re-crystallised after evaporation. The TLC 
evaluation showed that there were only three different single compounds. Therefore, the 
compounds which are the same were combined together.  Thus, three different single 
compounds were isolated and labelled as compound A, compound B and compound C. 
Evaluation with the Anisaldehyde spraying reagent also proved that the compounds 
were flavonoids. Evaluation of the pure flavonoid compounds was continued with 
structure elucidation of the three crystal obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.4 Compound Elucidation 
3.1.4.1 Compound A 
 
 
 
 
 
 
 
 
 
 
 
   Figure 3.1: Compound A 
 
 
 
Compound A was seen as crystals at room temperature with fan shaped crystals 
(seen as white spots on Figure 3.1) and in homeotropic alignment. Its melting point was 
recorded at 71ºC. Mass [M+]: 284; IR (KBr) cm-1: 3426 (OH), 2961 (OCH3), 2855, 
2726, 1764,1714 (C=O), 1539, 1449, 1376, 1309, 1207, 1162, 1087, 1019; 1HNMR 
(400MHz, DMSO) δ: 83.87 (3H, s, OCH3-4’), 6.18 (1H, d, H3’), 6.17 (1H, d, H5’), 
6.38 (1H, d, H6’), 6.39 (1H, d, H2’), 11.91 (1H, s, OH-5), 7.03 (1H, d, H6), 7.7 (1H, d, 
H8) ; 13CNMR δppm : 168.52 (C-2), 165.69 (C-3), 177.42 (C-4), 147.39 (C-5), 147.47 
(C-5a), 125.45 (C-6), 137.61 (C-7), 130.68 (C-8), 147.39 (C-8a), 94.43 (C-1’), 99.28 
(C-2’), 112.2 (C-3’), 121.48 (C-4’), 115.66 (C-5’), 104.55 (C-6’). 
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3.1.4.2 Compound B 
 
 
 
      Figure 3.2: Compound B 
 
Compound B was seen as granule shaped crystals at room temperature. Its 
melting point was recorded at 184ºC. EIMS m/z (% intensity): 330 [M+] (6), 314 (6), 
285 (6), 274 (6), 153 (6), 128 (6), 69 (6) ;  IR (KBr) cm-1: 3307 (OH), 2917 (OCH3), 
1654 (C=O), 1617,1594, 1556, 1510, 1441, 1372, 1338, 1305, 1258, 1235, 1201, 1164, 
1111, 1090, 1022; 1HNMR (400MHz, DMSO) δ: 3.3 (1H, d), 3,89 (3H, s, OCH3-7), 3.3 
(3H, s, OCH3-3’), 3.03 (2H, dd), 11.95 (1H, s, OH-5), 6.3 (1H, d, H-6), 6.1 (1H, d, H-
8), 7.03 (1H, d, H-2’); 13CNMR δppm:  165.62 (C-2), 162.52 (C-3), 177.42 (C-4), 
150.73 (C-5), 125.41 (C-6), 137.62 (C-7), 130.72 (C-8), 94.50 (C-1’), 99.35 (C-2’), 
112.25 (C-3’), 121.62 (C-4’), 115.72 (C-5’), 104.67 (C-6’). 
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3.1.4.3 Compound C 
 
     
     Figure 3.3: Compound C 
 
 
Compound C was seen as yellow needlelike crystal at room temperature. Its 
melting point is recorded at 202ºC. EIMS m/z (% intensity): 344 [M+] (11), 180 (11), 
166 (11), 122 (11) ;  IR (KBr) cm-1: 3436 (OH), 3286, 3119, 2917 (OCH3), 2848, 1369 
(C=O), 1615, 1511, 1465, 1402, 1370, 1309, 1292, 1250, 1170, 1139 ; 1HNMR 
(400MHz, DMSO) δ:3.8 (3H, s, OCH3 -7), 3.86 (3H,s, OCH3 -3’), 3.88 (3H, s, OCH3 -
4’), 6.18 (1H, d, H-8), 7.0 (1H, d, H-6), 7.03 1H, d, H-2’), 7.4 (1H, d, H-3’). 
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3.2 Toxicity Evaluation 
3.2.1 Dermal Irritation Evaluation 
               The mice were gauzed with equivalent dosage of 2000mg aqueous leaves 
extraction/kg body weight. For the control, the animal was gauzed with 0.9% of saline 
solution. The area of evaluation is on the dorsal abdominal skin of the mice. The area 
was shaven and checked for any injury or abrasion before the evaluation was started.  
  
             After the application of both the leaves extract of C. odorata and the control of 
saline solution,  any abnormal skin irritation was observed and characterisation of the 
skin irritation is as describe in Table 2.4 ( please refer page 32).  Besides that, abnormal 
responses were also observed and the mortality of all the animals. Observation is shown 
in Table 3.5. 
 
Table 3.5: Observation of the Dermal Irritation Evaluation 
Treated Control Observation 
(Female mice 25± 2g) 1 2 3 1 2 3 
Increased motor activity N N N N N N 
Tremor N N N N N N 
Chronic convulsion N N N N N N 
Tonic extension N N N N N N 
Muscle spasm N N N N N N 
Lose of righting reflex N N N N N N 
Decreased motor activity N N N N N N 
Ataxia N N N N N N 
Sedation N N N N N N 
Analgesia N N N N N N 
Hypnosis N N N N N N 
Anaesthesia N N N N N N 
Arching and rolling N N N N N N 
Ptosis N N N N N N 
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Table 3.5: Continued 
Salivation N N N N N N 
Writhing N N N N N N 
Breathing depression N N N N N N 
Breathing stimulation N N N N N N 
Breathing failure N N N N N N 
Muscle relaxation N N N N N N 
Piloerection N N N N N N 
Diarrhea N N N N N N 
Blister appearance N N N N N N 
Colour changes for skin N N N N N N 
Legend: N = Normal ;  A = Abnormal 
Table 3.6: Grading of Skin Reactions 
Erythema and Eschar Formation Grade
No erythema 0 
Very slight erythema (barely perceptible) 1 
Well defined erythema 2 
Moderate to severe erythema 3 
Severe erythema (beet redness) to eschar formation preventing grading of erythema 4 
Oedema Formation   
No oedema 0 
Very slight oedema (barely perceptible) 1 
Slightly oedema (edges of area well defined rising) 2 
Moderate oedema (raised approximately 1 mm) 3 
Severe oedema (raised more than 1 mm) and extending beyond area of exposure 4 
 
Table 3.7: Skin Reaction on Dermal Irritation Test Mice No.1  
Hours Remarks Mice no.1 
(treated) 
Weight 
(Kg) 1 24 48 72 96 120 144 168  
Erythema and 
Eschar  
Formation 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed. 
Oedema formation 25±  2 0 0 0 0 0 0 0 0 Normal, no 
changes seen. 
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Table 3.8: Skin Reaction on Dermal Irritation Test Mice No.2 
Hours Remarks Mice no.2 
(treated) 
Weight 
(Kg) 1 24 48 72 96 120 144 168  
Erythema and 
Eschar  
Formation 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
Oedema 
formation 
 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
 
Table 3.9: Skin Reaction on Dermal Irritation Test Mice No.3 
Hours Remarks Mice no.4 
(Control) 
Weight 
(Kg) 1 24 48 72 96 120 144 168  
Erythema and 
Eschar  
formation 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
Oedema 
formation 
 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
 
Table 3.10: Skin Reaction on Dermal Irritation Test Mice No.4 
Hours Remarks Mice no.4 
(Control) 
Weight 
(Kg) 1 24 48 72 96 120 144 168  
Erythema and 
Eschar  
formation 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
Oedema 
formation 
 
25± 2 0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
 
Legend of severity: 
1 = very slight 
2 = well define 
66 
 
3 = moderate 
4 = severe 
3.2.2 Acute Dermal Irritation Evaluation 
 Acute dermal irritation evaluation was done on white albino mice. This 
evaluation used the maximum dosage of 2000mg/kg of the aqueous extraction of          
C. odorata, directly on the shaven skin of the dorsal side of each mouse. While saline 
(0.9%) was used as control. Observation was then made on the first hour and 
continuously until the seventh day. Any signs of colour changes, blister appearance or 
inflammation on the skin were checked. The result of the acute dermal irritation 
evaluation is shown in Table 3.11. 
 
Table 3.11: Acute Dermal Irritation and Inflammation Test of Anique MMF 
No. of 
mice 
Average 
weight 
(Kg) 
Dosage 
Observed dermal irritation and 
inflammation 
Remarks 
   1 24 48 72 96 120 144 168  
3 Female 
(treated) 
25± 2 2000mg/
kg 
0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
1Female 
(control) 
25± 2 2000mg/
kg 
0 0 0 0 0 0 0 0 Normal, no 
changes 
observed 
 
 
The dermal irritation and acute dermal irritation evaluation showed that the 
extract of C. odorata did not cause any deterioration on the skin of the mice. No 
erythema, eschar or oedema was formed. Also, throughout the entire evaluation, there 
were no changes of behaviours observed on the tested animal. All the animals reacted 
normally until their fur grows back on the shaved skin. The maximum dosage was given 
to each animal and no negative effects were seen.  
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3.2.3 Oral Toxicity Evaluation 
Each mouse was dosed once orally with equivalent dosage of 2000 mg/kg body 
weight, i.e. 0.05 ml per animal. 
 
Table 3.12: Observation of Oral Toxicity Evaluation on Female Mice  
Treated Control Observation 
Female mice 25±2g 
 
1 2 3 4 5 6 
Increased motor activity N N N N N N 
Tremor N N N N N N 
Chronic convulsion N N N N N N 
Tonic extensor N N N N N N 
Piloerection N N N N N N 
Muscle spasm N N N N N N 
Loss of righting reflex N N N N N N 
Decreased motor activity N N N N N N 
Ataxia N N N N N N 
Sedation N N N N N N 
Analgesia N N N N N N 
Hypnosis N N N N N N 
Anaesthesia N N N N N N 
Arching and rolling N N N N N N 
Ptosis N N N N N N 
Salivation N N N N N N 
Writhing N N N N N N 
Breathing depression N N N N N N 
Breathing stimulation N N N N N N 
Breathing failure N N N N N N 
Muscle relaxation N N N N N N 
Diarrhea N N N N N N 
 
Note : Mice remained active during the whole experiment 
N = Normal A = Abnormal 
68 
 
 
Table 3.13: Observation of Oral Toxicity Evaluation on Male Mice 
Treated Control Observation 
     Male mice 25±2g 
 
1 2 3 4 5 6 
Increased motor activity N N N N N N 
Tremor N N N N N N 
Chronic convulsion N N N N N N 
Tonic extensor N N N N N N 
Piloerection N N N N N N 
Muscle spasm N N N N N N 
Loss of righting reflex N N N N N N 
Decreased motor activity N N N N N N 
Ataxia N N N N N N 
Sedation N N N N N N 
Analgesia N N N N N N 
Hypnosis N N N N N N 
Anaesthesia N N N N N N 
Arching and rolling N N N N N N 
Ptosis N N N N N N 
Salivation N N N N N N 
Writhing N N N N N N 
Breathing depression N N N N N N 
Breathing stimulation N N N N N N 
Breathing failure N N N N N N 
Muscle relaxation N N N N N N 
Diarrhea N N N N N N 
 
Note : Mice remained active during the whole experiment. 
N = Normal A = Abnormal 
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3.2.3 Acute Oral toxicity Evaluation 
The toxicity test and acute toxicity test were done on both male and female 
mice. The mice were fed orally using a feeding syringe water extract of C. odorata and 
at the maximum dosage of 2000mg/kg. Whereas the control mouse was given distilled 
water only. Then, observation was done on both behaviour and mortality of all the mice 
for 14 days.  
 
Table 3.14: Mice Acute Oral Toxicity Test Aqnique MMF 
Mortality/ no. of animals 
(Hrs) No. of mice 
Average Weight
(g) 
Dosage 
(mg/kg)
24 48 96 
Remarks 
3 Females 25± 2 2000 N N N No changes
Female (control) 25± 2 0 N N N No changes
3 Males 25± 2 2000 N N N No changes
Female (control) 25± 2 0 N N N No changes
 
 
Table 3.14 shows that throughout the evaluation all the mice survived and did 
not show any changes in their behaviour or any deterioration in health.  Both male and 
female showed the same results. No mortality was observed throughout 14 days after 
dosing. 
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3.3 Pharmacological Activities  
3.3.1 Anti-microbiology Evaluation 
3.3.1.2 Disc diffusion Evaluation 
Extracts of C. odorata were tested at various concentrations, ranging from 
100mg/ml to 800mg/ ml. Samples were extracted from three solvents which are 
petroleum ether, chloroform and methanol. Bacteria strains used were Staphylococcus 
aureus ATCC 25293 (SA 25293) Staphylococcus aureus ATCC 25923 (SA 25923), 
Erischia cocci ATCC 25922 (EC 25922) Erischia cocci ATCC 35213 (EC 35213), 
Klebsila pneumonia (KP) and Pseudomonas aeruginosa (PA).  
 
The extracts of C. odorata were loaded to 6mm diameter disc. The discs were 
prepared by using Whatman No. 1 paper and then sterilised. After sterilisation the discs 
were loaded with different concentration of the extract of C. odorata. The discs were 
loaded with 10µl of leaves extracts in three separate portions so that the discs absorb all 
fluid. The discs were then left to evaporate in a sterile environment.  
 
Culture media was prepared according to manufacturer’s specification (please 
refer page 34). Then, about 20ml of the sterile agar media was poured into sterile Petri 
dishes. The broths were distributed to final containers before autoclaving at 121°C for 
15 minutes. 
 
Cultures of bacteria were prepared one hour before the evaluation was started. 
One colony of bacteria tested was mixed in 5ml of sterilesed Mueller Hinton broth. The 
density of each inoculums was standardised according to McFarland 0.5 standards.  
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The bacterial suspensions were evenly spread on the surface of 4mm thickness 
of the Mueller Hinton Agar plates. Sterile cotton swabs were used to produce uniform 
growth organisms and Kirby-Bauer swabbing technique was used.   
 
Each Petri dish was divided into four sections according to different 
concentration of the loaded discs. Each section was labelled and then placed with the 
different concentration of prepared discs. The discs were placed in good contact on the 
seeded agar plates. This method was repeated three times for each bacterial suspension. 
The results for disc diffusion evaluation of the C. odorata extracts were compared to the 
standard antibiotic of Chloramphenicol with the concentration of 1mg/ml. The 
observation of the antibacterial activities is shown in Table 3.15 to 3.20 and Figure 3.1 
to 3.3. 
 
Table 3.15: Antibacterial Activity of Methanol Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 4±2 0 0 0 0 11±2 
200 4±2 2±2 0 0 0 11±2 
300 5±2 2±2 0 0 0 13±2 
400 5±2 2±2 0 0 0 13±2 
500 6±2 2±2 0 0 0 15±2 
600 8±2 2±2 0 0 0 16±2 
700 8±2 2±2 0 0 0 16±2 
800 9±2 3±2 0 0 0 16±2 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
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Table 3.16: Antibacterial Activity of Chloroform Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 - 0 0 0 0 14±2 
200 4±2 0 0 0 0 14±2 
300 4±2 0 0 0 0 15±2 
400 4±2 0 0 0 0 15±2 
500 6±2 2±2 0 0 0 15±2 
600 6±2 2±2 0 0 0 15±2 
700 6±2 4±2 0 0 0 15±2 
800 6±2 4±2 0 0 0 15±2 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm : Weak 
 4) Diameter of inhibition 0 mm : No activity  
 
 
Table 3.17: Antibacterial Activity of Petroleum Ether Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 0 0 0 0 0 0 
200 0 0 0 0 0 0 
300 0 0 0 0 0 0 
400 0 0 0 0 0 0 
500 0 0 0 0 0 0 
600 0 0 0 0 0 0 
700 0 0 0 0 0 0 
800 0 0 0 0 0 0 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
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Table 3.18: Antibacterial Activity of Standard Reference 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA25293 SA29213 EC 25922 EC 35213 KP PA 
Empty disc 0 0 0 0 0 0 
Empty disc with 
MeOH solvent  0 0 0 0 0 0 
Chloramphenicol 
(1mg/ml) 
27±2 26±2 30±2 24±2 30±2 24±2 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
 
 
 
3.3.1.3  Anti-fungal Evaluation  
 Methanol, chloroform and petroleum ether extracts (concentration 100mg/ml to 
800mg/ml) of C. odorata were tested on the fungi Candida albicans. However, all the 
extracts of C. odorata did not inhibit the growth of C. albicans. Since no inhibition was 
observed, test on anti fungal was stopped. This is because C. albicans is a very sensitive 
fungal. Inability to inhibit C. albicans means, there are no property of anti-fungal in      
C. odorata. The observations of the antifungal activity are shown in Table 3.19 to 3.22. 
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Table 3.19: Antifungal Activity of Methanol Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 0 0 0 0 0 0 
200 0 0 0 0 0 0 
300 0 0 0 0 0 0 
400 0 0 0 0 0 0 
500 0 0 0 0 0 0 
600 0 0 0 0 0 0 
700 0 0 0 0 0 0 
800 0 0 0 0 0 0 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
 
 
 
Table 3.20: Antifungal Activity of Chloroform Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 0 0 0 0 0 0 
200 0 0 0 0 0 0 
300 0 0 0 0 0 0 
400 0 0 0 0 0 0 
500 0 0 0 0 0 0 
600 0 0 0 0 0 0 
700 0 0 0 0 0 0 
800 0 0 0 0 0 0 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
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Table 3.21: Antifungal Activity of Petroleum Ether Extract of C. odorata 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA 25293 SA 29213 EC 25922 EC 35213 KP PA 
100 0 0 0 0 0 0 
200 0 0 0 0 0 0 
300 0 0 0 0 0 0 
400 0 0 0 0 0 0 
500 0 0 0 0 0 0 
600 0 0 0 0 0 0 
700 0 0 0 0 0 0 
800 0 0 0 0 0 0 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
 
 
Table 3.22: Antifungal Activity of Standard Reference 
Diameter of inhibition zone (mm) Extract conc. 
(mg/ml) SA25293 SA29213 EC25922 EC35213 KP PA 
Empty disc 0 0 0 0 0 0 
Empty disc with 
Methanol 
solvent 
0 0 0 0 0 0 
5-fluorocystina 
(1mg/ml) 15±2 18±2 18±2 19±2 20±2 15±2 
 
Inhibition strength indicator: 
 1) Diameter of inhibition zone ≥ 15 mm: Strong 
 2) Diameter of inhibition zone 10 mm -14.5 mm: Medium 
 3) Diameter of inhibition zone ≤ 9 mm: Weak 
 4) Diameter of inhibition 0 mm: No activity  
 
C3 C1 
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Figure 3.4: Antimicrobial activity of S. aureus ATCC 25293 against chloroform 
extract of  C. odorata at concentration of 100mg/ml (C1), 200mg/ml (C2), 300mg/ml 
(C3) and 400mg/ml (C4). 
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Figure 3.5: Antimicrobial activity of P. aruginosa against chloroform extract of C. 
odorata at the concentration of 100mg/ml(C1), 200mg/ml (C2), 300mg/ml (C3) and 
400mg/ml (C4). 
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Figure 3.6 : Antimicrobial activity of P. aruginosa against chloroform extract of  C. 
odorata at the concentration of 500mg/ml (C5), 600mg/ml (C6), 700mg/kg (C7) and 
800mg/ml (C8). 
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Figure 3.7: Antimicrobial activity of P. aruginosa against methanol extract of                  
C. odorata at the concentration of 200mg/ml (M2), 300mg/ml (M3) and 400mg/ml 
(M4). 
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Figure 3.8: Antimicrobial activity of S. aureus ATCC 29213 against methanol 
extract of C. odorata at the concentration of 100mg/ml (M1), 200mg/ml (M2), 
300mg/ml (M3)and 400mg/ml (M4). 
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Figure 3.9: Antimicrobial activity of S. aureus ATCC 29213 against methanol 
extract of C. odorata at the concentration of 500mg/ml (M5), 600mg/ml (M6), 
700mg/ml (M7) and 800mg/ml (M8). 
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3.3.2 Blood Coagulation Evaluation  
The samples used were petroleum ether, chloroform, methanol and aqueous 
extract of C. odorata. The concentrations prepared were ranging from 100mg/ml to 
500mg/ml. The control was drops of blood (BD) only. During the evaluation, the room 
temperature was 27°C. Blood was taken from adult rat.   
 
Ten drops of fresh blood was dropped onto white plate. Then, the leaves extacts 
of C. odorata was added on the blood. Saline was used as standard control and drops of 
blood only (without addition of any solvents or saline) were also used as control. 
Observation was made immediately and time was measured using a stop watch.  
 
According to Table 3.23, all the extracts of C. odorata did not increased time of 
blood coagulation, except for the methanol extract. The extracts were observed to 
prolong the coagulation time. The coagulation time was compared to the control 
(normal blood drop-BD), which only took 2 minutes to coagulate.  
 
Table 3.23: Influence of C. odorata on Blood Coagulation Time  
Extract 
concentration 
(mg/ml) 
Coagulation Time (minutes) 
Solvents PE CHCl3 MeOH H2O BD 
0 (solvent 
only) 
3.00 3.21 Immediately 2.00 
100 3.77 6.19 Immediately 3.28 
300 2.94 7.19 Immediately Negative 
500 2.94 7.82 Immediately Negative 
2 .00 
. 
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3.3.3 Anti-inflammatory Evaluation  
 The anti-inflammatory evaluation used the aqueous leaves extract of C. odorata 
with the concentration of 50, 100, 300, 500 and 1000mg/kg. tween 80 was used as 
vehicle to administered the plant extract into the mice. Also included in this evaluation 
were Tween 80, saline water and 10mg/kg of Indomethacine (standard drug) which 
were used as control. 
 
Each mouse was administered orally with the extracts and control using a 
feeding syringe. And before the injection of formaldehyde (inflammatory agent), the 
hind paw of each mouse was measured. One hour after the final drug administration, 
0.2ml (1% w/v) formaldehyde was subcutaneously injected into the plantar surface of 
the right hand paw. The volumes of the hind paws were measured after injection at 
third, sixth and 24th hour, till the inflammation disappeared (original paw volume 
obtained). The edema was expressed as a percentage of pre-injection right paw volume. 
Finally the anti-inflammatory effects of animals that received C. odorata extracts were 
compared with those in the control group and indomethacine administered group.  
 
The ratio of anti-inflammatory activity  was calculated by the following 
equation ; anti-inflammatory activity (%)=(1-D/C) x 100, Where D represents the 
percentage of difference of the paw volume after the administration of extract and C 
represents the percentage difference of the paw volume in the control group 
 
 
 
 
 
Table 3.24: Effects of C. odorata on Formaldehyde induced Paw Oedema in Rats 
Drugs 
(mg/kg) 
         Time 
        (hour) 
Saline Indomethacine 50 100 300 500 1000 
Normal  0.54 0.54 0.54 0.57 0.54 0.57 0.57 
0 0.65 0.68 0.70 0.73 0.70 0.74 0.69 
1 0.65 0.54 0.69 0.70 0.70 0.60 0.80 
3 0.64 0.68 0.67 0.73 0.78 0.70 0.64 
6 0.68 0.60 0.66 0.65 0.66 0.70 0.70 
24 0.60 0.59 0.61 0.63 0.60 0.63 0.61 
48 0.57 0.54 0.50 0.57 0.53 0.57 0.58 
72 0.54 Normal  Normal Normal  Normal Normal Normal  
 
 
Table 3.25: Effects of C. odorata on Formaldehyde induced Paw Oedema in Rats 
after 24 hours 
Dose (mg/kg) Saline Indo 50 100 300 500 1000 
Animals 3 3 3 3 3 3 3 
Paw volume (%) at 0 hour 20.37 25.93 29.63 28.07 32.08 29.82 21.06 
Differences in volume of 
paw  (%) after 6 hours 
25.93 11.11 22.22 14.04 22.22 22.81 22.81 
Differences in volume of 
paw  (%) after 24 hours 
11.11 9.26 12.96 10.5 11.11 3.42 7.02 
Anti-inflammatory effects 
(%) 
- 57.14 14.31 45.85 14.31 12.03 12.03 
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 After injecting the formaldehyde, inflammation can be seen on all of the 
animals.  The anti-inflammatory activity also can be observed on all animals, except for 
the animal that was given the saline solution. All the paw volume of the animal returned 
to normal after 24 hour, except for the mice given with saline solution. But the 
percentage of suppression was measured on the 6th hour.  
 
Figure 3.10: Paw Volume of Formaldehyde-Induced Inflammation of Mouse  
        Against Time  
82 
 
 
  
Paw Volume of Formaldehyde-Induced Inflammation of Mouse against Time
35 
30 
25 
10 
15 
20 
In
cr
ea
se
 in
 P
aw
 S
iz
e 
(m
m
) 
5 
0 
0 6 24 
Time (Hour)
Saline Indo 50 100 300 500 1000 
 
 
 
83 
 
3.3.4 Wound Healing Studies 
 Crude extracts of C. odorata were subjected to wound healing studies which 
was done on white albino mice weighed 25g, obtained from the animal house of 
Biological Science Institute, University of Malaya. Observation was done throughout 16 
days. All experimental tools and their living cages were disinfected with 70% of alcohol 
to prevent infection and ensure cleanliness. They were provided with food and water ad 
libitum throughout the evaluation.  
 
 The animals were left unrestrained and their hair was shaved on the dorsal side. 
Ethanol 70% was used as antiseptic for the shaved region. An incision was made on 
each mice vertically using a sharp shaving razor with the length of 1cm. The wound was 
left undressed to the open environment and no local antimicrobial agents were used. 
The animals were kept in separate cages according to the concentration of extracts. The 
control animal was swab with acriflavine lotion.   
 
 Throughout the evaluation, there were no changes of behaviours in all the 
animals. There were also no signs of infection or irritation. It took 10 days for the 
treated animals to heal and to grow back their fur. However it took 15 days for the 
control animals to heal and there was also presence of scab observed. Moreover, 
inflammation was seen very obvious on the control animals. As for the treated animals, 
the wound healed faster and no presence of scab was seen. Though scaring was obvious 
on both control and treated animals. 
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Table 3.26: Observation of the Wound healing Studies 
C. odorata Leaves Extract Concentration (mg/kg) Dosage 
(mg/kg) 
Acriflavine lotion 
(control) 100 300 500 
Day 0 
Fresh open wound, 
bleeding 
Fresh open 
wound, 
bleeding 
Fresh open 
wound, bleeding 
Fresh open 
wound, bleeding 
Day 1 
Inflammation (++) 
Red (+++) 
Blood coagulation on 
open wound 
No 
inflammation 
Red (++) 
Open wound 
No inflammation 
Red (+) 
Open wound 
No inflammation, 
no redness, open 
wound 
Day 2 
Inflammation 
(+++) 
Redness (+++) 
Scab formed 
No 
inflammation 
Redness (+) 
Wound starts 
to close/heal 
(+) 
No inflammation 
Redness (+) 
Wound starts to 
close/heal 
(+++) 
No inflammation 
No redness 
Wound starts to 
close/heal 
(+++) 
Day 3 
No inflammation  
Redness (+) 
Scab seen 
No 
inflammation 
Redness (+) 
Wound starts 
to close/heal 
(+) 
No inflammation 
No redness 
Healing (++) 
No inflammation  
No redness 
Healing (++) 
Day 4 
No inflammation 
No redness 
Scab observed 
No 
inflammation 
No redness 
Healing (+) 
No inflammation  
No redness 
Healing (++) 
No inflammation  
No redness 
Healing (++) 
Day 5 
No inflammation 
No redness 
Scab observed 
No 
inflammation 
No redness 
Healing (+) 
No inflammation  
No redness 
Healing (+) 
No inflammation  
No redness 
Healing (+) 
Day 6  
No inflammation 
No redness 
Scab observed 
No 
inflammation 
No redness 
Healed 
Scar (+++) 
No inflammation  
No redness 
Healed 
Scar (++) 
No inflammation  
No redness 
Healed 
Scar (+) 
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Table 3.26: Continued 
 
Day 7 
No inflammation 
No redness 
Scab observed 
No 
inflammation 
No redness 
Scar (++) 
No inflammation  
No redness 
Healed 
Scar (+) 
No inflammation  
No redness 
Healed 
No scar 
Day 8 
No inflammation 
No scab  
Redness (+) 
No 
inflammation 
No redness 
Scar (+) 
Hair starts to 
grow 
No inflammation  
No redness 
Healed 
No scar 
No inflammation  
No redness 
Healed 
No scar 
Day 9  
No inflammation 
No scab 
Redness (+) 
Healing (+) 
No 
inflammation 
No redness 
Healed 
No scar 
Normal 
Hair starts to 
grow 
Normal 
Hair starts to 
grow 
Day 10 
No inflammation 
No scab 
Redness (+) 
Healing (++) 
Normal Normal Normal 
Day 11 
No redness 
Healing (+++) 
Normal Normal  Normal  
Day 12 Healing (+++) Normal Normal Normal 
Day 13 Healing (++++) Normal Normal Normal 
Day 14 
Healed 
Scar (++) 
Normal Normal Normal 
Day 15 Scar (++) Normal Normal Normal 
Day 16 Scar (+) Normal Normal Normal 
Legend: 
+ Vague 
++ Evident  
+++ Obvious  
++++ Very obvious  
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CHAPTER 4  
 DISCUSSION 
 
4.1 Phytochemical Analysis 
4.1.1 Preliminary Analysis 
  From the preliminary analysis and colour test, it was found that the leave 
powder extract of C. odorata contains terpenoid, flavonoid and alkaloid. These 
compounds are common in the compositae family (Heywood et al., 1977). Alkaloid and 
flavonoid are compounds which have medicinal properties and are widely used. This 
result is also parallel with the phytochemical studies of the plant done by Afolabi et al., 
2007.   
  
To isolate the flavonoid compound, trial and error method was used to obtain the 
suitable solvent system of extraction and to find suitable solvent of extraction.  It was 
found that methanol extract isolated the flavonoid compound best and this is accordance 
with Ling et al., 2007c and Afolabi et al., 2007.  
 
 
4.1.2 Crude extract 
The crude extract of C. odorata was subjected to HPLC and GCMS analysis. 
The fresh leaves were extracted using petroleum ether, hexane and chloroform. The 
extraction was done in 12 days and then filtered for three times. After the filtration, two 
layers of liquid were obtained. The essential oil was seen on the top layer and was then 
subjected to GCMS analysis. Meanwhile, the crude solvent extract was subjected to 
HPLC analysis. 
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4.1.2.1 GCMS Analysis 
One drop of each solvent extract of the leaf was diluted in a small vial 
containing chloroform. Chloroform was used as solvent vehicle to prevent the column 
of the GCMS from clogging. The injection into the GCMS was done in triplicate and 
each analysis was run in 20 minutes.  
 
The GCMS analysis detected three major compounds which are caryophyllene 
(20), germacrene D (21) and hexadecoic acid (24). This result of the isolated compound 
of the GCMS analysis was also reported by Dieneba et al., 1992. 
 
The first compound-caryophylene (20) is a mixture of hydrocarbons, primarily 
sesquiterpenes. So far there are three hydrocarbons derived from caryophylene (20). 
They are alpha, beta and γ-caryophyllenes, which own individual properties. Generally, 
caryophylene (20) is reported to be non steroidal anti-inflammatory agent. 
Complementary to its anti-inflammatory agents, it is reported that they have analgesic, 
antipyretic, and platelet-inhibitory actions. Caryophyllene (20) is also reported used 
primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders 
associated with pain and inflammation (Heywood et al., 1977). 
 
 The second compound is Germacrene (21) or occasionally germacrane which 
refers to a subset of volatile organic hydrocarbons, specifically sesquiterpenes. There 
are two major molecules of germacrene (21) which are germacrene A and germacrene 
D. Germacrenes (21) are normally produced in a number of plant species for their 
antimicrobial and insecticidal properties. It also functions as insect pheromones 
(Heywood et al., 1977).  
The last compound which is hexadecanoic acid (24) or palmitic acid occurs in 
oil of vetiver, Canadian snakeroot, pimento, myrrh, cascarilla, in the seed oils of 
ambrette, celery, anise, parsley and carrot, as well as in expressed almond oil. Palmitic 
acid is present in 11 percent of all commercial fixed oils and it is insoluble in water 
(Heywood et al., 1977). Meanwhile, hexadecanoic acid (24) is reported to be an enzyme 
inhibitor. It is an agent that combines with an enzyme in such manner as to prevent the 
normal substrate-enzyme combination and the catalytic reaction. The World Health 
Organization (WHO) claims there is convincing evidence that dietary intake of palmitic 
acid increases risk of developing cardiovascular diseases (WHO/FAO Consultant 
Organisation, 2003). 
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4.1.2.2 HPLC Analysis 
 HPLC chromatogram (please refer to appendix) indicated five major peaks.  The 
peak numbers identified were peak numbers 17 (retention time 15.71), 18 (retention 
time 16.23), 20 (retention time 17.20), 22 (retention time 19.92) and peak number 23 
(retention time 21.19). This result is as shown by Ling et al., 2006. The flavonoids 
isolated by HPLC are also parallel with Ling et al., 2007a; Ling et al., 2007b and 
Suksamrarn 2004. 
 
 Peak number 17 was assigned to quercetin-4 methyl ether and peak number 18 
is aromadendrin-4’-methyl ether. As for peak number 20, there were three compound 
identified, taxifolin-7-methyl ether, taxifolin-4’-methyl ether and quercetin-7-methyl 
ether. Peak number 22 was assigned to two compounds which are kaempferol-4’-methyl 
ether and   eridicytol-7, 4’-dimehyl ether. Lastly, peak number 23 was assigned to 
quercetin-7,4’-dimethyl ether. 
 
 
4.1.3 Column Chromatography 
The column chromatography method was used to isolate flavonoid compound of 
the methanolic leaf extract of C. odorata. It was done using the 2cm x 60cm, 3cm x 
70cm and 4cm x 80cm column sizes. Slurry method was used for packing the silica gel 
in the entire column. The slurry method is the best column packing method but it must 
be done carefully and using the suitable solvent.   
 
The most important aspect of packing the column is creating an evenly 
distributed and packed stationary phase. Cracks, air, bubbles and channelling will lead 
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to poor separation and not to mention the expensive wastage of chemical solvents and 
materials.  
 
When adding sample into the packed column, it must be done cautiously so that 
the top column can be remained even. After adding the sample, some white sand is 
sprinkled on top so that it remained even when solvent is added. It is also very 
important not to let the column run dry at any time as this will allow air enter into the 
column, which can result in uneven bands and poor separation.  
 
Small vials were used to collect the eluent with approximate volume of 5ml. 
This was to ascertain that the compounds were separated carefully.  Then, collected the 
eluent was evaporated to about 1ml and spotted on a TLC plate to determine the 
presence of  compounds. A single spot would indicate a single compound. A developed 
TLC plate that showed the same colour after spraying with Anisaldehyde reagent and 
with the same Rf value would be combined. As these would indicate that the same 
compound were collected in different vials.  
 
Crystal of pure compound was obtained after evaporation of the solvents.  If an 
oily residue was obtained, the vials were scratched to induce crystallization. The 
crystals were then weighed and its physical characteristic (shape and colour) noted. The 
structure elucidation was done through determination of the melting point, NMR, IR 
and the MS analysis.   
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4.1.3.2 Isolated Compound 
 There were 11 flavonoids present in the leaves of C. odorata that had been 
identified and reported by Ling et al., 2006. The targeted compound flavonoid is a class 
of diverse biological properties. It has been reported as anti-oxidant, anti-inflammatory, 
anti-allergic, anti-carcinogenic, vitamin C sparing (Kuhnau, 1976) as well as chelate 
metals. It also stimulates the immune system and also reduces allergic response, 
prevents formation of carcinogens, impedes cancer growth and protection against 
bacteria and viruses (Ling et al., 2007a). 
 
 Through the column chromatography, three flavonoid compounds were able to 
be isolated and identified. The structures of the isolated compounds were elucidated 
according to 1HNMR, 13CNMR, IR, and MS data. The compounds isolated were 
labelled as Compound A, Compound B and Compound C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3.2.1 Compound A 
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Figure 4.5: Chemical Structure of Compound A 
 
The mass spectrum revealed that the molecular weight for Compound A is [M+]  
284 fit for C16H12O5. The IR spectrum showed a hydrogen bonded signal at 1714cm-1 
which confirmed the presence of hydrogen bonded carbonyl at the C-4 to C-5 position. 
Signals at 2961cm-1 and 3426cm-1 confirmed the presence of methoxyl and hydroxyl 
bonded hydrogen respectively. 
 
 The 1HNMR suggested the presence of one methoxy with the signal at δ3.89, 
positioned at C-4’. The other proton signals can be assigned as follow; δ6.39 (C-2’), 
δ6.18 (C-3’), δ6 .17 (C-5’), δ6.38 (C-6’), δ7.03 (C-6) and δ7.70 (C-8).  
  
 13CNMR showed the carbon signal for carboxyl at 177.42 which can be assigned 
to position at C-4. While the methoxyl signal was at 56.40 and could be assigned to      
C-4’. The other carbon signals were as follow; δ168.52 (C-2), δ165.69 (C-3), δ177.42 
(C-4), δ147.39 (C-5), δ 147.47 (C-5a), δ125.45 (C-6), δ137.61 (C-7), δ130.68 (C-8), 
δ147.39 (C-8a), δ94.43 (C-1’),  δ99.28 (C-2’),  δ112.2 (C-3’),  δ121.48 (C-4’),  δ115.66 
(C-5’),  δ104.55 (C-6’). 
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 The Compound A was assigned to a structure of 5,7-dihydroxy-2-(4-
methoxyphenyl)chromen-4-one. This compound had been isolated previously and 
known acacetin or apigenin-4’-methyl ether (Suksamrarn et al., 2004). It had been 
isolated from the aqueous flower extract of C. odorata. Through my literature review, 
this is the first time the compound is isolated from the leave extract of C. odorata. 
Compared to the 11 flavonoid compound which was isolated from the leave extract of 
C. odorata by Ling et al., 2007a where it has not mentioned anything about the 
compound.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3.2.2 Compound B  
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Figure 4.6: Chemical Structure of Compound B 
 
The mass spectrum showed that Compound B was having [M+] 330, fit for 
C17H14O7. The IR spectrum indicated a hydrogen bonded carbonyl signal at 1654cm-1 
which confirmed the presence of a carbonyl at the C-4 to C-5 position and had a typical 
structure of a flavone. Signals at 3306cm-1 and 2917cm-1 also confirmed the presence of 
a hydroxyl and methoxyl functional group respectively. 
 
The position of 1H NMR suggested the presence of two methoxy with the signal  
at δ3.89 and could be assigned to C-7 and C-4’ as compared to Ling et al., 2007b. The 
other proton signals were 7.7 (d, C-3’), 7.3 (d, C-2’), 6.1 (d, C-8) and 6.3 (d, C-6) which 
could be assigned to aromatic protons. The mass spectrum fragmented into methoxyl 
(OCH3) with peak 330MHz. 
 
 The presence of OH at C-5 position was confirmed from the 1HNMR by the 
signal at δ 11.95 typical of hydroxyl bonded hydrogen. Based on the proton signal for 
C-2’, C-3 and C-6’, the hydroxyl signal on the Ring B could only be placed at the C-5’ 
position. 
95 
 
96 
 
 13CNMR showed the carbon signal for carboxyl at 177.5 that could be assigned 
at C-4 position. It also proved that the methoxy signal at 56.4 and could be assigned to 
the position of C-7. The other carbon signals were as follow; δ165.62 (C-2), δ162.52 
(C-3), δ177.42 (C-4), δ150.73 (C-5), δ125.41 (C-6), δ137.62 (C-7), δ130.72 (C-8), 
δ94.50 (C-1’), δ99.35 (C-2’), δ112.25 (C-3’), δ121.62 (C-4’), δ115.72 (C-5’), δ104.67 
(C-6’). 
 
 Compound B could be assigned to the structure of 3,5-dihydroxy-2-(3-hydroxy-
4-methoxy-phenyl)-7-methoxy-chromen-4-one. This compound had also been 
previously isolated and known as ombuine; flavone, 4’,7-dimethoxy-3,3’,5-trihydroxy 
or 7,4’-Di-O-methylquercetin (Ling et al., 2007a;  Pisutthanan et al., 2006). It was also 
found in the ethanol extract of the leaf of C. odorata (Phan et al., 2001a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3.2.3 Compound C 
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Figure 4.7: Chemical Structure of Compound C 
 
The mass spectrum showed that Compound C was having [M+] 344, fit for  
C18H16O7. Meanwhile, the IR spectrum showed a hydrogen bonded signal at 1639cm-1 
which confirmed the presence of carbonyl at the C-4 to C-5 position. Signals at 
3436cm-1 and 2917cm-1 confirmed the presence of hydroxyl and methoyxl respectively. 
 
 The position of the 1HNMR suggested the presence of three methoxy with the 
signal at δ 3.89. This signals could be assigned to C-7, C-4’ and C-3’. The other proton 
signals were at 7.03 (C-2’), 7.4 (C-3’), 7.0 (C-6) and 6.2 (C-8). The mass spectrum 
fragmented into methoxyl (OCH3) with the peak 344MHZ. 
 
 The presence of OH at C-5 position was confirmed from the 1HNMR by the 
signal at δ11.95, typical of a hydrogen bonded hydroxyl. Based on the proton signal for 
C-2’, C-3’, C6 and C-8, then the methoxy signal could only be placed at C-3’ and C-4’ 
position.  
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 Compound C could be assigned to the structure of 2-(3,4-dimethoxyphenyl)-3,5-
dihydroxy-7-methoxy-chromen-4-one. From my literature review, this compound has 
not been mentioned in the plant extract of C. odorata. 
 
 
4.2 Pharmacological Analysis 
4.2.1 Toxicity Evaluation 
4.2.1.1 Oral Toxicity Evaluation 
Toxicity test was done using two-month-old white albino mice. Before the 
evaluation, the mice were kept in four separate cages, separating the males from the 
females and left to acclimatize to the new surrounding for three days. They were fed 
with food and water. Their cages were also cleaned and sanitized regularly. 12 hours 
prior to the experiment, all the mice were weighed and then fasted. The water extracts 
of C. odorata were prepared according to their weight. The concentration was 
2000mg/kg, which was the maximum dosage for oral toxicity test. 
 
 Each animal was force fed with 1ml of the extract using a feeding syringe. This 
was to ensure that the extract was taken by the animals as it would be directly inserted 
into their trachea. This had to be done carefully as it may cause harm to the animal and 
even death if done improperly. The animals were observed through out the 14 days. 
Their eating habit, their alertness and their behaviours had been carefully observed. 
 
 During the whole extend of the oral toxicity evaluation, there were no abnormal 
behaviours. The animals remained active and normal with their usual weight and eating 
habit. Acute oral toxicity test was also done with the maximum dosage of 2000mg/kg. 
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The mortality of the animals was observed for three consecutive days. At the end of the 
third day, no fatality was seen.  
 
 The dosage of 2000mg/kg is the limit dose stipulated by Organization for 
Economic Cooperation and Development (OECD). The limit test is primarily used in 
situation where the investigator has information indicating that the test material is likely 
to non toxic or has low toxicity (Etuk et al., 2006). Overall the aqueous leave extract of 
C. odorata did not caused any side effects on the animals. The result of acute oral 
toxicity study at the limit dose had also shown there was no toxicity. Therefore, the 
aqueous leave extract of this plant is non toxic and it is safe for oral formulation.  
 
 Based on my literature reviews, no proper toxicity evaluation had been done on 
the crude aqueous extract of C. odorata on life subjects. Cytoxic effect which was done 
by Ling et al., 2007c, was on the flavonoid of the plant extract and it was done on the 
liver and kidney cells only. 
 
 
4.2.1.2 Dermal Irritation Evaluation 
Dermal irritation test was done on white albino mice. As mentioned earlier,            
C. odorata is usually used directly on the skin. Therefore, it is important to determine 
whether it will cause any type of skin irritation. The dermal irritation test was done by 
shaving a 1cm x 1cm area on the dorsal side of the mice. After shaving, the area was 
checked for any skin abnormalities or cuts to avoid interruption of the test observation. 
The shaven area is cleaned and disinfect with alcohol. Then, the prepared aqueous 
extract of C. odorata (2000mg/kg) was applied three times on the skin.  Dark green 
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colour of the extract can be seen on the applied area. The extract was applied once daily 
and was observed for two weeks.  
 
 During the whole experiment, all the animals behaved normally. They did not 
seem to be uncomfortable nor scratch the shaven area. No swelling or redness on the 
shaven area of the animals during the observation. By the end of the two weeks 
observation, the whole shaven area was covered back with hair. Therefore, no adverse 
side effects were seen on the experimented animals and this proved that the extract is 
safe to be used directly on the skin. 
  
 Since the poultice of the leave of C. odorata is used directly on the skin, it is 
important that dermal irritation evaluation is looked upon. As for what I’ve known, 
there was no reported dermal irritation evaluation which had been done on this plant 
before.  
 
 
4.2.2 Antiinflammatory Study  
Effects of drugs and acute phase of inflammation can be studied by models 
induced with inflammatory agents such as carrageenan, dextrane, formaldehyde, 
serotonin, histamine and bradykinin in rat paws. Chronic inflammation models by 
implanting the foreign body under the skin are used to study the effects of the drug on 
the proliferation phase of inflammation (Suleyman et al., 2002). 
 
It is known that formaldehyde-induced inflammation usually involves two 
distinct phases. It has been proposed that the first phase reflects direct stimulation of 
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noci-receptors, while the latter phase maybe associated with inflammation mediators 
(Suleyman et al., 2002).  
 
 
4.2.2.1 Formaldehyde Induced Paw Oedema Evaluation 
  To induce oedema or inflammation, formaldehyde was used as an inflammation 
agent. The injection of formaldehyde will increase the production of bradykinin, which 
is an inflammation mediator (Fereira et al., 1992). The role of bradykinin in the 
pathogenesis of formaldehyde-induced inflammation was reported by Kulkarni, 1986. 
 
 For the anti-inflammatory result, normal is the time when the paws of the mice 
were measured before any injection of extract administered to them. Zero hour is the 
measurement of the paw immediately after the injection of formaldehyde on the sub 
plantar paw hind leg of the mice. Then, the measurement of the paw was taken on the 
first, third and sixth hour. Measurement of the paw was then taken daily until they reach 
normal or the original paw measurement obtained (Suleyman et al., 1999).  
 
 After the injection of formaldehyde, the average percentage of inflammation of 
all the mice was 26.71%. This means that formaldehyde had successfully induced 
inflammation. The result of this evaluation showed that all paw measurements were 
reduced to normal on the second day, except for the saline solution.  
 
 Observation on the first hour showed the reduction of inflammation on all 
animals, except for the saline solution. The standard drug Indomethacine showed 
immediate inflammation reduction of 25.93%. The leaf extract of the plant decreased to 
1.43% (50mg/kg), 4.29%, (100mg/kg) and 18.92% (500mg/kg). As for the 1000mg/kg, 
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the inflammation increased to another 15.94% for the first hour. The inflammation 
started to decrease on the third hour until normal paw measurement was achieved on the 
third day. 
 
 On the sixth hour, the lowest percentage on paw measurement was 
Indomethacine (11.11%) and followed by extract concentration of 100mg/kg (14.04%).  
The percentage of paw measurement of the concentration 50, 300, 500 and 1000mg/kg 
were relatively the same that was 22%.  
 
On the 24th hour, the extract concentration of 100mg/kg showed the reduction of 
measurement to 10.5%. As for the concentration of 50, 300, 500 and 1000mg/kg, the 
percentage of paw oedema had reduced to 12.96%, 11.11%, 3.42% and 7.02% 
respectively. And on the 48th hour, all mice had reached their original paw 
measurement.  
 
The percentage of anti-inflammatory effect wad 57.14% for Indomethacine, 
45.85% for extract concentration of 100mg/kg, 14.31% for both 50 and 300mg/kg and 
12.03 for both 500 and 1000mg/kg extract concentration. 
 
On the second day, all the extracts given reached normal paw volume. 
Therefore, the result on the sixth and the 24th hour were used for comparison. This is to 
determine which extract will reduce inflammation in a better and faster way. It can be 
deduced that the concentration of 100mg/kg showed the best result. Although the effect 
of anti-inflammation was slow at first, but after the sixth hour the effect was rapid. And 
compared to the standard drug Indomethacine, the effect of extract concentration of 
100mg/kg is 80.24% as effective as Indomethacine.   
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To my knowledge, this is the first formaldehyde induced paw oedema evaluation 
done with C. odorata leaf extract. This evaluation validate the anti-inflammatory 
activity of this plant as mentioned by Ling et al., 2006; Phan et al., 2001a; Phan et al., 
2001b; Akinmoladun et al., 2007 and Dieneba et al., 1992.  
 
 
4.2.3 Blood Coagulation Test 
Blood coagulation is part of an important host defence mechanism termed 
hemostasis. Upon vessel injury, platelets adhere to macromolecules in the sub 
endothelial tissues and then aggregate to form the primary hemostatic plug. The 
platelets stimulate the local activation of plasma coagulation factors, leading to 
generation of a fibrin clot that reinforces the platelet aggregate. Later, as wound healing 
occurs, the platelet aggregate and fibrin clot are broken down. Mechanisms that restrict 
formation of platelet aggregates and fibrin clots to sites of injury are necessary to 
maintain the fluidity of the blood. Normal blood coagulation time for human is 190-300 
seconds (Mary et al., 2003).  
 
Platelets are the major constituents of thrombus and a source of powerful 
vasoconstrictors that can cause vasospasm and enhance coagulation by diminishing 
blood flow (Rodger, 1988). The antiplatelet therapy is one of the revolutionise 
mechanism related to atherogenesis (Cimmniello and Toschi, 1999).   
 
All the extracts of C. odorata in the observation of blood coagulation showed a 
positive anti-coagulation mechanism at the concentration of 100mg/ml, except for the 
methanol extract. The plant extracts prolong coagulation time compared to the control 
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normal blood drop. It was also observed that as concentration increased, time taken for 
the blood to coagulate was also increased.  
 
However, for the methanol extract (concentration of 100mg/ml), immediate 
blood clot was seen after adding the extract to the blood drop. This may due to active 
flavonoid compounds in the methanol extract. As reported by Oweyele et al, 2008, the 
anti-inflammatory of C. odorata is related to the flavonoid compound of the plant. This 
result also validates the wound healing (Phan et al., 2001b) activity as rapid blood clot 
helps to increase wound healing process.   
 
 
4.2.4 Antimicrobial Evaluation  
 The antimicrobial consists of antifungal and antibacterial evaluation. Both these 
evaluations are important to identify the antimicrobial properties of leave extract of           
C. odorata.  There are two sensitivity methods which are suitable, they are disc 
diffusion and a dilution technique. For the disc diffusion technique, a disc of blotting 
paper is used on a plate of sensitivity testing agar (inoculated with test organisms). Then 
observation is made after 24 hours by examining the areas of growth around the disc 
agar. The dilution sensitivity test involves the measurement of the minimum inhibitory 
concentration (MIC). This can be measured by the concentration of bactericidal or 
lowest concentration of antimicrobial. This method involves dilution of an antimicrobial 
to a broth or agar medium using extracts and antibiotics by comparison (Bauer et al., 
1966; Brown and Blowers, 1978). 
 
The antifungal evaluation may also be tested using the same method; disc 
diffusion or dilution technique. But the medium (agar and broth) is replaced with 
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suitable medium. Antifungal that can be used are nystatin, flucytosine or imidazole 
agents (Bauer et al., 1966; Brown and Blowers, 1978). 
 
 
4.2.4.2 Disc Paper Disc Diffusion Assay 
The antibacterial evaluation of C. odorata showed positive effect of inhibition 
against gram positive bacteria, (S. aureus) gram negative bacteria and P. aeruginosa 
bacteria). Though negative inhibition was shown against bacteria K. pneumonia, the 
antibacterial result showed that methanolic extract of C. odorata at the concentration of 
800mg/ml was the most efficient to inhibit S. aureus ATCC 25923. The percentage of 
inhibition was 33.33% compared to Chloramphenicol.  This result is considered 
medium inhibition activity as the inhibition zone was only 9mm.  
 
Meanwhile, for the second strain of S. aureus ATCC 29213, the most efficient 
plant extract was chloroform (C800) with the concentration of 800mg/ml. The 
percentage of inhibition by C800 was 15.38% compared to Chloramphenicol. It was 
considered as weak inhibition activity as the inhibition zone was only 4mm.  
 
P. aeruginosa was inhibited the highest by the methanol leaves extract of         
C. odorata with the concentration up to 800mg/ml. The percentage of inhibition was 
62.50% compared to Chloramphenicol. The inhibition of the extract against P. 
aeruginosa was considered as strong inhibition as the inhibition zone was 16 mm. There 
was no inhibition observed for both strain of E. coli ATCC 25922 and E. coli ATCC 
35213 and K. pneumonia. 
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As for the anti-fungal test which had been shown in the result, no positive 
observation was obtained. Candida albican is a low strength fungal which can be easily 
inhibited (Viejo-Diaz et al., 2004). Since the extract did not show any inhibition, 
therefore, C. odorata is not an anti-fungal agent.  
 
Overall, the result of gram negative bacteria showed only a weak to mild activity 
of the leave extract of C. odorata. Strong activity was seen on the gram negative 
bacteria, but no activity was observed on the fungal strain.  
 
Antimicrobial evaluation has also been done by other authors which shows the 
effects of antimicrobial activity of C. odorata. Yet, there is no author who has 
specifically done the antimicrobial evolution on the methanol leaf extract of this plant. 
Evaluations by Odunbaku and Ilusanya, 2008 used the whole plant methanolic extract. 
Suksamrarn et al., 2004 and Ling et al., 2007c emphasize only on the antimicrobial of 
the flavonoid extract of the plant. 
 
 
4.2.5 Dermal Wound Healing Evaluation 
Wound healing is the process of repair that follows injury to the skin and other 
soft tissues. Wounds may result from trauma or from surgical incision. In addition, 
pressure ulcers (also known as decubitus ulcers or bed sores), a type of skin ulcer, might 
also be considered wounds. Following the injury, an inflammation response occurs and 
the cells below the dermis (the deepest skin layer) begin to increase collagen 
(connective tissue) production. Later, the epithelial tissue (the outer skin layer) is 
regenerated (Bert et al., 1996). 
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The process of wound healing is a complex and encompassing a number of 
over-lapping phases, including inflammation, epithelialisation, angiogenesis, matrix 
deposition and tissue remodelling. These processes are essential to restore the structure 
and functional integrity of the damaged tissue. During inflammation, the formation of 
blood clot re-establishes haemostasis and provides provisional matrix for cell migration 
(Gopinath et al., 2004). 
 
The result for wound healing test was positive. Crude water extract of                
C. odorata healed the wound faster compared to acriflavine lotion. The healing of 
wound was also cleaner with no inflammation and no formation of scab observed.  
 
Both the acriflavine lotion and the extract of C. odorata were applied as soon as 
the incision was made. Incisions were made at the back of the mice so that they will not 
be able to scratch the wound. This is because scratching will worsen the wound and 
prolong the healing process. Incision on the back of the mice was also easier to be 
observed. 
 
It was observed that concentration of 300mg/kg and 500mg/kg showed rapid 
wound healing. Scaring was observed on all tested mice. As for the concentration of 
300 and 500mg/kg extract, scaring was seen on the sixth day and seventh day only. On 
the eighth day, the scar was gone and the hair stated to grow on the ninth day.  
 
 A number of wound healing or wound healing related studies were done for this 
plant. But most of the studies done were using the fractionation extract of the leaf or 
whole plant only and the evaluation was done through in vitro methods. Phan et al., 
2001b emphasizes the phenolic wound healing compounds of the leaves of C. odorata 
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on cultured skin cells. Another study by Phan et al., 2001a uses antioxidant evaluation 
on human cells, in vitro. In Vietnam, clinical trial was done on burn victims on  the 
stimulatory effect of C. odorata extract on the formulation of granulation tissue and 
wound re-epthelialization was proven clinically and histoogically (Phan et al., 2001a 
and Ling et al., 2007b). Again, this clinical trial used Eupolin ointment, a compound 
isolated from the leaf extract of C. odorata. 
 
Based on my literature reviews, an evaluation of wound specifically on the 
crude extract of the leaf of C. odorata has never been reported. An open wound incision 
has also never been done on life subject using the crude leaf extract of this plant. This 
evaluation is important as traditional preparation use the poultice and fresh leave of this 
plant (Ling et al., 2007c). Therefore, this is the first open wound incision evaluation of 
the methanol leave extract of C. odorata. 
 
Generally the pharmacological studies show that the leaves extract of C. odorata; 
(i) is non toxic and do not cause any type of dermal irritation 
(ii) has an anti-bacterial properties  
(iii) has anti-inflammatory properties 
(iv) has an anti-coagulant properties and 
(v) promote wound healing.  
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CHAPTER FIVE 
CONCLUSION 
 
Chromolaena odorata of the family Compositae was investigated for its 
chemical constituents and pharmacological properties. C. odorata was reported to be 
used as wound healing plant locally. Therefore, the pharmacological activities 
investigated were biological activities that were related to wound healing activity.  
 
 Premilinary phytochemical analysis revealed that, C. odorata consists of 
terpenoid, flavanoid, alkaloid and essential oil. The major compound of the plant is 
terpenoid as it is the major compound of the Compositae family. The targeted 
compound to be isolated for the present study was therefore flavonoid.  
 
Through the literature reviews, it was known that there are 11 known compound 
of flavonoids reported for C. odorata. However through this study, only three 
compounds were successfully extracted through column chromatography. The three 
compounds extracted were identified as flavonoid.  
 
GCMS analysis revealed three compounds from the hexane extraction. They 
were caryophyllene (20), germacrene D (21) and hexadecoic acid (24).  The HPLC 
analysis had identified seven compounds from the methanol extract of this plant, which 
are all identified as flavonoid. They were aromadendrin-4’-methyl ether; taxifolin-7-
methyl ether; taxifolin-4’-methyl ether; quercetin-7-methyl ether; kaempferol-4’-methyl 
ether;    eridicytol-7, 4’-dimehyl ether and quercetin-7,4’-dimethyl ether. 
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The pharmacological analysis revealed that C. odorata is safe to be applied 
directly on the skin and is safe to be consumed as there was no adverse effect during the 
toxicity and dermal irritation evaluation. Meanwhile, for the wound healing study, the 
extract of C. odorata took only seven days to healed wound compared to the 
Acriflavine lotion. There was no scars observed after the ninth day and the fur of the 
mouse starts to grow on the tenth day. Acriflavine lotion took 14 days to heal and the 
scar still can be seen after the 16th day. It is obvious that C. odorata helps to heal wound 
faster. 
 
 Wound is also shield from infection as C. odorata also shows positive activity of 
antimicrobial. Though, only weak activity recorded on antibacterial activity on gram 
positive bacteria (S. aureus) and mild antimicrobial activity on gram negative bacteria 
(P. aeruginosa). And no antifungal activity was found on C. albican. Still, this 
antibacterial activity will assist in the wound healing process. 
 
Anti-inflammatory evaluation proved that the extract of C. odorata reduced 
inflammation at the concentration of 100mg/kg and is 80.24% as effective as the 
standard drug indomethacine. Meanwhile, the petroleum ether and chloroform extract of 
the leaf at the concentration of 100mg/ml showed positive anti-coagulant activity. 
However, the methanol extract, at concentration of 100mg/ml, showed negative anti-
coagulant activity. Anti-coagulant properties open the possibilities of isolating drugs for 
arthrosclerosis condition. At the same time as the methanolic extract support the ability 
of C. odorata as a wound healing plant.  
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  Although the use of herbal medicines has been widely accepted, they are still 
unable to be correlated to the clinical practice and diagnostic and therapeutic. In herbal 
medicines, the classification of diseases is based on symptoms. Therefore, it becomes 
difficult to define with certainty, the pharmacological activity to be evaluated with the 
respect to the nature of traditionally prescribed use of an indigenous drug. Nevertheless, 
presumption based on nature of traditional use and evaluation of specific beneficial 
activity of indigenous drugs have  been found to be successfully approach in medicinal 
plant research. 
 
It is hope that the findings and results from this study will help to enlighten us 
more on the benefits of C. odorata, besides proving its usefulness as claimed by the 
locals of its wound healing property. The plant is easily available but known as harmful 
weed all over the world.  At the moment, people around the world are very keen in 
medicinal herbs and many foresee that medicinal herbs and plants are the trend of 
tomorrow medicines.  
 
Since the C. odorata is proved to help in wound healing activities, my 
suggestion is to bring the research further for clinical trials.  C. odorata is proven save 
for consumption, therefore its ability as wound healing agents on superficial and 
internal wounds, such as gastric ulcer should be analyze on.  
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APPENDIX 1 
 
A) IR Spectrum of Compound A 
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C) 13CNMR Spectrum of Compound A  
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E) IR Spectrum of Compound B 
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F) 1HNMR Chromatogram of Compound B 
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G) 13CNMR Spectrum of Compound B 
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H) MS Chromatogram of Compound C 
 
 
O
OOH
OH
H3CO
OCH3
OCH3
 
132 
 
I) IR spectrum of Compound C 
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J) 1HNMR of Compound C 
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B) HPLC spectrum of peak No. 17 of the methanol extract of C. odorata 
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C) HPLC spectrum of peak No. 18 of the methanol extract of C. odorata 
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D) HPLC spectrum of peak No. 20 of the methanol extract of C. odorata 
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E) HPLC spectrum of peak No. 22 of the methanol extract of C. odorata 
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F) HPLC spectrum of peak No. 23 of the methanol extract of C. odorata 
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APPENDIX 3 
 
A) GCMS Chromatogram of Chloroform Extract of the leaves of Chromolaena odorata 
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B) GCMS Chromatogram of Hexane Extract of the leaves of Chromolaena odorata 
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C) GCMS Chromatogram of Petroleum Ether Extract of the leaves of Chromolaena odorata 
 
 
